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“Nevertheless the difference in mind between man 
and the higher animals, great as it is, certainly is one of 
degree and not of kind. We have seen that the senses 
and intuitions, the various emotions and faculties, 
such as love, memory, attention, curiosity, imitation, 
reason, etc., of which man boasts, may be found in 
an incipient, or even sometimes in a well-developed 
condition, in the lower animals.” 
(Darwin, 1871), Descent of Man, page 105 
 
 
 
 
 
 
 
 
 
 
 
Für meine Eltern Sylvia und Berndt 
                                                                                                                                                                                                  
Zusammenfassung 
 
Zum limbischen System gehören Gehirnregionen, die unter anderem an der 
Verarbeitung von Informationen beteiligt sind, die mit Angst und Furcht in Verbindung 
gebracht werden können. Zu diesem System gehören der Hippokampus, der mediale 
präfrontale Kortex und die Amygdala. Die neuronalen Netzwerke des limbischen 
Systems modulieren im Anschluss an diese Informationsverarbeitung unter anderem 
die Stressreaktion durch ihre Interaktion mit dem Nukleus paraventrikularis des 
Hypothalamus, dessen Neurone "Corticotropin-releasing hormone" (CRH) 
ausschütten. CRH stimuliert die Produktion von Kortikosteroiden in der Glandula 
adrenalis, die das Verhalten, das Immunsystem und den Energiehaushalt 
beeinflussen.    
Die neuronalen Netzwerke des limbischen Systems und die Hirnregionen mit denen 
sie interagieren sind an der Pathophysiologie von Angststörungen beteiligt. Dieser 
Zusammenhang wurde in Tiermodellen gezeigt, indem die elektrische Aktivität 
bestimmter Regionen des limbischen Systems mit Angst- und Furcht-assoziiertem 
Verhalten korreliert werden konnte. Eine wichtige Rolle hierbei spielt die laterale (LA) 
und basolaterale (BLA) Amygdala. 
In diesem Kontext gibt es aus neurobiologischer Sicht eine Wissenslücke zwischen 
der Aktivität und Plastizität einzelner Neurone und den damit verbundenen 
Veränderungen des gesamten Netzwerkes als Prozessierungseinheit. Der Grund 
hierfür ist teilweise das unvollständige Wissen über den Aufbau der entsprechenden 
neuronalen Netzwerke.  
Für die Untersuchung der Aktivität und Plastizität von anatomisch klar definierten 
Netzwerken der LA und BLA wurde ein in vitro "Voltage-sensitive dye imaging" 
(VSDI)-basiertes Messverfahren in Hirnschnitten von Mäusen entwickelt und die 
gewonnenen Daten unter Verwendung eines eigens programmierten Algorithmus 
analysiert. Damit konnte gezeigt werden, dass innerhalb des neuronalen Netzwerkes 
der LA unter Verwendung desselben elektrischen Stimulationsprotokolls 
(hochfrequente Stimulation (HFS)), das bekannt dafür ist neuronale Plastizität zu 
induzieren, gegensätzliche und räumlich voneinander getrennte Veränderungen in 
der Aktivitätsstärke hervorgerufen werden können. Auf diesem Befund aufbauend 
wurde untersucht ob Mediatoren der Stressreaktion diese Art der Plastizität 
beeinflussen. Es wurde beobachtet, dass CRH das Verhältnis von HFS-vermittelter 
Potenzierung und Depression der Aktivität in der LA konzentrationsabhängig in 
Richtung der Potenzierung verschiebt. Darüber hinaus konnte gezeigt werden, dass 
"Corticotropin-releasing hormone receptor type 1" (CRHR1) an diesem Effekt beteiligt 
ist. 
Ähnliche Befunde ergab die Applikation von Kortikosteron unter Verwendung dieses 
experimentellen Ansatzes. Es konnte sowohl in der LA, als auch in der BLA gezeigt 
werden, dass dieses Stresshormon die basale neuronale Netzwerkaktivität erhöht. 
Außerdem wurde die Potenzierung der Netzwerkaktivität durch Kortikosteron erhöht. 
In einer weiteren Experimentserie wurde die Stärke der Netzwerkpotenzierung in  
Gehirnschnitten von Mäusen miteinander verglichen, die sich in Bezug auf ihr 
Angstverhalten unterscheiden. Es konnte gezeigt werden, dass das neuronale 
Netzwerk der BLA in Hirnschnitten von ängstlichen Mäusen stärker durch HFS 
potenziert wird, als das Netzwerk der BLA von Mäusen, die weniger Angst zeigen. 
Abschließend wurden unterschiedliche Klassen von Pharmazeutika (Selektive 
Serotonin-Wiederaufnahmehemmer (SSRIs), Serotonin-Noradrenalin-
Wiederaufnahmehemmer (SNRIs), Trizyklische Antidepressiva (TCAs) und 
Antipsychotika) im Hinblick auf ihren Einfluss auf die basale Netzwerkaktivität der LA 
und BLA untersucht. Die Ergebnisse zeigten, dass diese Substanzklassen die 
Netzwerkaktivität in der LA und BLA abschwächen. 
In der Zusammenschau all dieser Befunde konnte ein Zusammenhang zwischen 
Stress und erhöhter Aktivität in einer Gehirnregion hergestellt werden, die mit Furcht 
im Zusammenhang steht. Außerdem konnte eine Verbindung zwischen einem 
ängstlichen Verhaltensphänotypen und einer netzwerkspezifischen 
Informationsverarbeitung dargelegt werden. Darüber hinaus konnten neue 
Erkenntnisse bezüglich des Wirkungsprofils von verschiedenen Klassen von 
Pharmazeutika (SSRIs, SNRIs, TCAs und Antipsychotika) auf der Ebene der 
Regulation der Aktivität von neuronalen Netzen gewonnen werden. Diese Befunde 
können dazu beitragen die Wissenslücke zwischen der Aktivität von Neuronen bzw. 
neuronalen Netzen und Furcht bzw. Angst zu schließen. 
 
 
Abstract 
 
The limbic system comprises brain structures that are involved in the processing of 
information related to fear and anxiety. This system contains the hippocampus, the 
medial prefrontal cortex and the amygdala. Downstream of this information 
processing, limbic circuits modulate, among others, the stress responses via their 
interaction with the paraventricular nucleus of the hypothalamus. Subsequently, 
neurons of this nucleus release corticotropin-releasing hormone (CRH), which in turn 
enhances the production of corticosteroids by the adrenal glands. This affects 
behaviour, the immune response and energy homeostasis.   
The limbic brain nuclei and their output targets can be associated to the 
pathophysiology of anxiety disorders. This involvement has been shown by use of 
animal models, where the activity of distinct subfields of the limbic system could be 
correlated with occurrence of fear- and anxiety-like behaviour. The lateral (LA) and 
basolateral (BLA) nuclei of the amygdala display such changes in activity upon the 
expression of associated behaviour. 
On the neurobiological level, a gap of knowledge exists between changes in the 
activity and plasticity of single neurons and the concomitant changes of the network 
as a whole processing unit. This gap is partially due to the incomplete knowledge of 
the neuronal circuitry.  
To investigate network activity and plasticity in these nuclei in vitro, a voltage-
sensitive dye imaging assay in conjunction with advanced data processing was 
developed for mouse brain slices, reliably containing distinct parts of the LA and BLA. 
By this means, we showed that these neuronal networks respond spatially 
segregated to the same plasticity-inducing stimulus (i.e. high-frequency stimulation 
(HFS)) in opposite ways. Based on these findings, the effect of mediators of the 
stress responses was investigated on network plasticity. CRH, in a concentration-
dependent manner, reshaped the LA responses induced by HFS by shifting the 
balance between potentiation and depression in the direction of potentiation. 
Furthermore, we demonstrated that corticotropin-releasing hormone receptor type 1 
(CRHR1) is involved in mediating these plastic changes.   
The application of corticosterone within the same paradigm has shown that this 
stress hormone increases the strength of basal neuronal network activity and the 
magnitude of potentiation in the LA and BLA. Furthermore, the use of brain slices 
 
 
from inbred mouse lines that differ with respect to their anxiety-related behaviour 
revealed that the strength of network potentiation is increased in the BLA of animals 
showing high anxiety-related behaviour. Finally, distinct classes of pharmaceuticals 
(selective serotonin reuptake inhibitors (SSRIs), serotonin noradrenalin reuptake 
inhibitors (SNRIs), tricyclic antidepressants (TCAs), and antipsychotics) were used to 
investigate their putative role in the regulation of the activity in the LA and BLA, and it 
could be shown that these substances are capable of dampening LA and BLA 
network activity. 
To conclude, this study provides evidence for a link between stress and an increased 
cue-responsiveness of a fear-mediating brain structure and also links a pathological 
and stable anxious phenotype with differences in the memory-encoding capacity of 
this system. Furthermore, it gives insights into the method of action of distinct classes 
of commonly used pharmaceutical components (SSRIs, SNRIs, TCAs, and 
antipsychotics) on a neuronal network level. These data might help to further bridge 
the knowledge gap between neuronal network activity and fear- and anxiety-related 
behaviour. 
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1 Introduction 
 
1.1 The limbic system in the mammalian brain 
 
In the 1930s, brain regions thought to be involved in the processing and expression 
of emotions were put together in one brain circuitry, named the "limbic system" 
(Adolphs, 2010). The mammalian limbic system can be described as a processing 
linkage between subcortical structures such as the hypothalamus, the periaqueductal 
gray, and nuclei of the brain stem on the one hand, and cortical regions such as 
sensory or motor cortices on the other hand (Adolphs, 2010). The regions frequently 
referred to as part of the limbic system include the hippocampus, the amygdala, the 
insula and the medial prefrontal cortex (Adolphs, 2010; Price and Drevets, 2010; 
Stein and Steckler, 2010; Cisler and Olatunji, 2012).   
In the following, emphasis will be put on these limbic structures in the context of 
being part of a brain circuitry mediating fear and anxiety (Aggleton, 2000; LeDoux, 
2007; Stein and Steckler, 2010; Adolphs, 2013). 
 
1.2 The brain circuitry of fear and anxiety 
 
As stated above, the limbic circuitry is part of brain structures that mediate fear and 
anxiety comprises the amygdala, the hippocampus, the insula, and the medial 
prefrontal cortex. 
Figure 1.2.-1 depicts this network together with some known input and output 
pathways. Although studies describing parts of the functional connectivity within this 
system have been published (Szinyei et al., 2000; Kim et al., 2011; Orsini et al., 
2011), directions of information flow were intentionally excluded from this scheme to 
put emphasis that full knowledge of functional interconnections has not been 
completely deciphered.  
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Figure 1.2.-1. Basic scheme of the limbic brain system with known connectivity as indicated trough 
black lines. adapted from Stein and Steckler (2010)
 
 
Sensory afferences arising from thalamic nuclei and association cortices terminate in 
the amygdala and insula (LeDoux, 1991; LeDoux, 2007; Stein and Steckler, 2010). 
Within the amygdala, the respective signals are processed in the lateral (LA) and 
basolateral (BLA) nucleus (LeDoux, 1991; Szinyei et al., 2000; LeDoux, 2007; Stein 
and Steckler, 2010). After integration of diverse limbic inter- and intra-circuit 
information, the amygdala projects to the hippocampus (Andersen et al., 2007), the 
periaqueductal gray (LeDoux, 2007), the brainstem (Veening et al., 1984), the 
hypothalamus (Sah et al., 2003), striatal structures, such as the bed nucleus of the 
stria terminalis (Walker et al., 2009) or the ventral striatum (LeDoux, 2007), and 
regions of the cortex (Aggleton, 2000; LeDoux, 2007). From a functional point of 
view, these projections may be attributed to further signal processing (Johansen, et 
al., 2012), storage of information which can be related to fear memory (Ramirez, et 
al., 2013), contributions to the control of the bodily expression of fear (LeDoux, 2007) 
or anxiety (Cryan and Holmes, 2005), and the regulation of the stress responses 
(Fink, 2006).  
 
 
Sensory
information
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Amygdala
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prefrontal
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The insula can be linked to the processing of sensory information related to negative 
emotions and also to the regulation of the autonomous nervous system in response 
to emotion-related stimuli (Adolphs, 2010; Stein and Steckler, 2010). 
The dorsal and ventral parts of the medial prefrontal cortex are involved in the 
regulation of intra-limbic processing, which in turn is related to fear and fear memory 
(Morgan and LeDoux, 1995; Sotres-Bayon and Quirk, 2010; Mountney et al., 2011). 
This includes signal modulation through “higher” cognitive processes (Stein and 
Steckler, 2010) within the dorso-medial prefrontal cortex, which influences the activity 
of the amygdala via signalling through the ventro-medial prefrontal cortex (Baratta et 
al., 2008; Stein and Steckler, 2010).  
The limbic brain circuitry interacts with the hypothalamus (Fink, 2006) via the 
amygdala (Price, 2003; Andersen et al., 2007), the hippocampus (Andersen, 2007), 
and the medial prefrontal cortex (Radley, 2009). Within this framework, cognitive 
processes related to fear and anxiety influence a brain nucleus mediating the stress 
responses via the activation of the hypothalamic-pituitary-adrenal (HPA) axis (Fink, 
2006; Mountney, 2011; Adolphs, 2013).  
 
1.3 The HPA axis 
 
The hypothalamus receives inputs, among other brain structures, from the limbic 
circuitry and is involved in the initiation of the stress responses. The parvocellular 
part of the paraventricular nucleus (PVN) contains corticotropin-releasing hormone 
(CRH) and arginine vasopressin (AVP) synthesizing neurons (Fink, 2006). CRH, via 
corticotropin-releasing hormone receptor type 1 (CRHR1), and AVP, via the V1b 
receptor, stimulate the release of adrenocorticotropic hormone (ACTH) from the 
anterior pituitary (Papadimitriou and Priftis, 2009; Refojo and Holsboer, 2009). In 
addition, CRH from PVN neurons is released centrally and influences the production 
of CRH within other brain structures e.g. the central amygdala (CeA), thereby 
shaping the overall stress responses of the brain (Roozendaal et al., 2002; Shekhar 
et al., 2005; Fink, 2006). The release of ACTH, in turn, stimulates the release of 
adrenal steroids (Refojo and Holsboer, 2009). These include cortisol in humans and 
corticosterone (Cort) in rodents (Fink, 2006). 
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Besides exerting a negative feedback on hypothalamic CRH secretion, adrenal 
steroids also influence behaviour, the immune response, and energy homeostasis 
(Fink, 2006); for further details regarding CRH and Cort in a brain-circuit specific 
manner see chapter: 1.5.3.2. 
 
1.4 Psychiatric disorders that are related to fear and anxiety 
 
Fear can be seen as a state that results from a confrontation of an organism with a 
situation threatening its homeostasis (Damasio and Carvalho, 2013). As a 
consequence, the organism tries to escape this situation to avoid damage and to 
reduce the anxious feeling (Adolphs, 2013; Damasio and Carvalho, 2013). Anxiety, in 
contrast to fear, represents a state of an organism awaiting putative threatening 
situations (Adolphs, 2013).  
When suffering from anxiety disorders, the anxious feeling persists without being 
ever confronted with the threatening situation, which seriously impacts on the 
individual (Cryan and Holmes, 2005). 
According to the DSM IV criteria for humans, anxiety disorders include (Stein and 
Steckler, 2010):  
Agoraphobia with or without history of panic disorder 
Social phobia 
Simple phobia 
Panic disorder 
Generalized anxiety disorder 
Obsessive compulsive disorder 
Posttraumatic stress disorder 
Acute stress disorder 
Substances used to treat these psychiatric conditions are e.g. citalopram, 
venlafaxine, and clomipramine (Benkert and Hippius, 2011). 
For more information about pharmacotherapy, see chapter: 1.5.3.3 
In psychiatric research, animal models are widely used to correlate neurobiological 
endophenotypes with a defined anxiety-like behavioural phenotype (Cryan and 
Holmes, 2005). By that, researchers aim to gain insights into the mechanisms that 
contribute to the development of these psychiatric diseases (Bourin et al., 2007).  
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1.4.1 Mouse models of anxiety disorders  
 
The development of mouse models offers an animal model that is accessible to 
genetic tools (Cryan and Holmes, 2005; Bourin et al., 2007; Maren, 2008; Neumann 
et al., 2011). Conditioned models are commonly established by using pavlovian fear 
conditioning, where a neutral stimulus (conditioned stimulus (CS)), such as a tone or 
certain contextual cues, is paired with an aversive stimulus (unconditioned stimulus 
(US)), such as a foot shock. After conditioning and subsequent fear memory 
formation, the animals show fear-related behaviour, e.g. freezing, upon presentation 
of CS (Rodrigues et al., 2004; Apergis-Schoute et al., 2005; Cryan and Holmes, 
2005). By use of this paradigm, researchers are able to investigate the modulation of 
acquired fear memory, thereby possibly mimicking the oblivion of an acquired fearful 
experience. It could be shown that, after conditioning, single and repeated 
presentation of the CS is capable of decreasing the freezing response of the animal 
(Myers and Davis, 2007; Quirk et al., 2010).  The creation of unconditioned models 
can be achieved either by selection of animals upon a behavioural phenotype within 
a clearly defined paradigm and subsequent inbreeding of these mice (Cryan and 
Holmes, 2005; Bourin et al., 2007; Krömer et al., 2005), or via genetic manipulation 
(van Gaalen et al., 2002; Cryan and Holmes, 2005).  
An example of an unconditioned mouse model is the high vs. normal anxiety-related 
behaviour (HAB/NAB) mouse model. Mice are selected according to their behaviour 
on the elevated-plus maze, where the time spent on the open arms is used as the 
selection criterion for subsequent bi-directional breeding within the groups (Krömer, 
et al., 2005; Bourin et al., 2007). Employing this mouse model in conjunction with fear 
conditioning has shown that HAB mice display a higher degree of freezing in 
comparison to NAB mice in a contextual fear conditioning paradigm (Yen et al., 
2012). 
Another example of unconditioned mouse models is transgenic mice. Advances 
within these approaches allow the generation of conditional knock-out mouse lines to 
overcome the problem of compensatory genetic mechanisms, which may complicate 
the causal linkage between the inactivated gene and the observed alteration in 
behaviour (Cryan and Holmes, 2005). 
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This technique has been successfully applied to selectively knock-out CRHR1 and to 
link CRHR1 expression in glutamatergic neurons in forebrain structures, including the 
hippocampus and the amygdala, with anxiety-related behaviour (Refojo et al., 2011). 
The authors showed that these knock-out mice exhibited more entries into the lit 
compartment of the dark-light box and a higher locomotor activity (Refojo et al., 
2011). Since the dark-light box paradigms based on the assumption that more entries 
into the lit compartment reflect a less anxious state of the animal (Cryan and Holmes, 
2005), the authors provided evidence that CRHR1 is involved in the mediation of 
anxiety-associated behaviour (Refojo et al., 2011). 
Unconditioned models can be used to study anxiety, whereas conditioned ones to 
examine fear and fear memory formation (Cryan and Holmes, 2005; LeDoux, 2007) 
with respect to the specific contribution of distinct brain circuits and underlying 
neurobiological mechanisms.   
A limbic brain structure significantly involved in many aspects of fear, fear memory, 
and anxiety is the amygdala (Davis et al., 1994; Aggleton, 2000; Blair et al., 2001; 
Sah et al., 2003; Rainnie et al., 2004; Cryan and Holmes, 2005; Shekhar et al., 2005; 
LeDoux, 2007; Gallagher et al., 2008; Maren, 2008; Ehrlich et al., 2009; Johansen et 
al., 2010; Johansen et al., 2011; Kim et al., 2011; Johansen et al., 2012; Mahan and 
Ressler, 2012; Pare and Duvarci, 2012; Damasio and Carvalho, 2013). In the 
following chapter, emphasis will be put on this region with anatomical and functional 
aspects.  
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1.5 The amygdala 
 
Anatomical considerations  
 
The amygdala is a brain structure that lies in the anterior-medial portion of each 
temporal lobe (Aggleton, 2000). It was first described in the early 19th century by 
Burdach (Sah et al., 2003). Since then, its anatomical organization was investigated 
in more detail, resulting in the view that the amygdala can be subdivided in 
approximately 13 nuclei and cortical regions that are interconnected for the 
processing of sensory and polymodal information (Aggleton, 2000; Sah et al., 2003). 
Although this consensus exists, there is also another view, in which nuclei of the 
amygdala are not an entity but extensions of the cortex and the striatum (LeDoux, 
2007). The present study is based on the view that the amygdala can be subdivided 
in several key nuclei that are specifically interconnected to fulfil distinct roles in the 
integration and computation of incoming information related to emotions such as fear 
and anxiety (LeDoux, 2007). Unless otherwise stated, the data described in the 
following originate from rodent studies. 
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1.5.1 Overview of anatomical subdivisions of the amygdala 
According to Paxinos (2004) and Schmitt et al. (2012), the  amygdaloid complex can 
be subdivided as follows: 
Supranuclear division of amygdala 
  Superficial cortical-like nuclear group 
    Olfactory amygdala 
      Anterior amygdaloid area 
      Nucleus of the lateral olfactory tract 
      Anterior cortical nucleus 
      Postero-lateral cortical nucleus 
      Amygdalo-piriform transition area 
      Peri-amygdaloid complex 
      Posterior amygdaloid nucleus 
    Vomeronasal cortical-like amygdala 
      Nucleus of the accessory olfactory tract 
      Postero-medial cortical nucleus 
      Amygdalo-hippocampal area 
      Bed nucleus of the accessory olfactory tract 
    Vomeronasal amygdala 
      Medial extended amygdala 
        Medial amygdaloid complex 
        Medial sub-lenticular extended amygdala 
        Medial subdivision of the bed nucleus of the stria terminalis 
        Medial division of the supra-capsular division of the bed nucleus of the stria 
        terminalis 
        Intra-amygdaloid division of the bed nucleus of the stria terminalis 
  Extended Amygdala 
    Central extended amygdala 
      Central amygdaloid nucleus 
      Central sub-lenticular extended amygdala 
      Lateral division of the bed nucleus of the stria terminalis 
      Lateral supra-capsular division of the bed nucleus of the stria terminalis 
      Interstitial nucleus of the posterior limb of the anterior commissure 
  Latero-basal nuclear complex 
    Lateral amygdala 
    Basolateral amygdaloid nucleus 
    Basomedial amygdaloid nucleus  
    Ventral basolateral amygdaloid nucleus 
  Unclassified cell group 
    Amygdalo-striatal transition zone 
    Interfascicular islands 
      Interfascicular islands, granular part 
      Interfascicular islands, parvocellular part 
      Intercalated masses 
      Intramedullary griseum 
      Para-striatal nucleus 
      Bed nucleus of the anterior commissure 
      Subventricular nucleus 
      Fusiform nucleus 
      Nucleus of the commissural component of the stria terminalis 
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The order depicted in this column was obtained and confounded by the use of 
ontogenetic, histo- and immunocytochemical techniques (Paxinos, 2004; Schmitt et 
al., 2012). In the following, emphasis will be put on key nuclei and circuits that are 
known to be involved in the processing and storage of fear memories and the 
expression of fear and anxiety. These nuclei and cell groups appear in red and bold 
in the above hierarchy.  
 
1.5.2 Anatomical organization of amygdalar key nuclei 
 
Central extended amygdala  
The CeA, bordered laterally by the basolateral complex and medially by the striatum, 
can be subdivided from dorsal to ventral in the centrolateral  nucleus (lCe) and the 
centromedial nucleus (mCe) (Sah et al., 2003) (Figure 1.5.2-2). From a 
developmental point of view, these nuclei originate from the striatum which is also 
reflected through their efferences and their neuronal architecture (Sah et al., 2003).  
 
Deep nuclei of the amygdala 
The LA and the BLA can be grouped within the deep nuclei group. These nuclei are 
located dorsally within the amygdaloid complex and are bordered laterally by the 
external capsule (EC) and medially by the CeA. From the dorsal to ventral axis, these 
nuclei are arranged from the LA to the BLA (Aggleton, 2000; Sah et al., 2003) (Figure 
1.5.2-2). Embryologically and functionally, these nuclei resemble to cortical circuits 
(Sah et al., 2003).  
 
Intercalated masses 
The intercalated cell masses can be subdivided based on their location relative to the 
key nuclei of the amygdala. The lateral intercalated cells are located laterally to the 
LA (Ehrlich et al., 2009), whereas the medial population of intercalated cells is 
located between the LA/BLA and the CeA. This population of cells can further be 
subdivided in dorsal intercalated cells, main intercalated cells and ventral intercalated 
cells (Pare and Duvarci, 2012). These populations are put together in the group of 
“medial intercalated cells” in Figure 1.5.2-2, which was built according to: Sah et al., 
(2003); LeDoux (2007); Ehrlich et al., (2009); Pare and Duvarci, (2012). 
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Figure 1.5.2-2. Key nuclei, cell groups, and fibre tracts within the amygdaloid complex and their anatomical location
along the dorsal/ventral and lateral/medial axes. EC = External capsule, lITC = Lateral intercalated cells, mITC = Medial
intercalated cells, dLA = Dorsal lateral amygdala, vlLA = Ventro-lateral lateral amygdala, vmLA = Ventro-medial lateral
amygdala, BLA = Basolateral amygdala, lCe = Centrolateral amygdala, mCe = Centromedial amygdala, AST = Amygdalo-
striatal transition area, D = dorsal, V = ventral, L = lateral, M = medial.
 
 
 
1.5.3 Functional connectivity within amygdalar key nuclei 
 
The amygdalar neuronal network is strongly heterogeneously distributed with respect 
to the flow of electrical signals (LeDoux, 2007). Inter-nuclear flow of activity follows 
the tendency to travel from dorsal to ventral and from lateral to medial, which can 
also be observed on the level of axonal connectivity (Krettek and Price, 1978; Ehrlich 
et al., 2009; Pare and Duvarci, 2012). 
The spreading of excitatory and inhibitory neuronal activity within the LA and BLA is 
reciprocally regulated through feedback and feedforward circuits (Ehrlich et al., 
2009). Inhibitory circuits mainly contribute to this signal processing by a local intra-
nuclear (Ehrlich et al., 2009) regulation of the output of their projection neurons. 
The flow of excitatory and inhibitory neuronal activity was investigated within the LA 
in coronal and horizontal slices (Samson and Pare, 2006). This study showed that in 
coronal slices, excitatory responses could be detected with the highest prevalence 
upon application of glutamate in the direction from dorsal to ventral whereas 
inhibitory signalling appeared to be diffuse. In horizontal brain slices, excitation 
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mainly spreads from the EC towards a medial direction. Inhibitory activity could be 
detected within this section from medial to lateral (Samson and Pare, 2006). 
Another study put emphasis on the observation that feedback inhibition along the 
transverse section of the LA gates the strength of excitatory activity and, by that, 
patterns the LA in discrete processing entities along this axis (Samson et al., 2003).  
The fact that the LA, via convergence of cortical and thalamic afferences (LeDoux, 
2007), is a major sensory input region, together with the above mentioned 
observations, exemplifies the capacity of this nucleus to modulate the direction and 
strength of signal propagation by a fine regulation of neuronal activity through 
inhibitory circuits. The dominance of excitatory signalling is emphasized by the higher 
number of excitatory projection neurons in comparison to the number of interneurons 
in the LA and BLA (Davis et al., 1994; Ehrlich et al., 2009; Orsini and Maren, 2012). 
In contrast, the striatum-like CeA mainly contain inhibitory neurons (Ehrlich et al., 
2009; Orsini and Maren, 2012). The lCe receives most inputs from the LA, the BLA, 
and intercalated cells, where they undergo intra-nuclear processing through inhibitory 
networks (Pare and Duvarci, 2012). Subsequently, signals are conveyed to the mCe, 
which in turn projects to downstream targets of the amygdala (Pare and Duvarci, 
2012). Besides inputs from the lCe, the mCe also receives direct inputs from the BLA 
and intercalated cells (Pare and Duvarci, 2012).  
Within the amygdaloid complex, the intercalated cells exert their function by inhibiting 
and thereby a “fine tuning” of the activity within distinct nuclei. On the one hand, 
these cells modulate the processing of cortical sensory inputs and, on the other 
hand, shape the activity of the lCe and mCe, one of the major output circuits of the 
amygdala (Pare and Duvarci, 2012). 
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Figure 1.5.3-3 depicts the known functional connectivity but also connections with so 
far undefined function among amygdalar key nuclei together with other brain 
structures. The LA appears as a functional entity, including the dorsal, ventrolateral 
and ventromedial nucleus in this scheme. Inputs arising from known fibre tracks such 
as the EC or internal capsule (IC) are indicated. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5.3-3. Functional connectivity of amygdala key nuclei and cell groups. Please note the weighted excitatory drive
within the LA and BLA, which is indicated through bold “+” signs and tendencies of structures to be either excitatory (red) or
inhibitory (blue). EC = External capsule, IC = Internal capsule, LA = Lateral amygdala, BLA = Basolateral amygdala, lCe =
Centrolateral amygdala, mCe = Centromedial amygdala, lITC = Lateral intercalated cells, dITC = Dorsal intercalated cells, mITC =
Main intercalated cells, vITC = Ventral intercalated cells.
 
 
Figure 1.5.3-3 also illustrates the large portion of excitatory drive within the LA and 
BLA and, in contrast to that, the dominance of inhibitory circuits in the CeA and 
intercalated cell masses. 
Figure 1.5.3-3 was prepared according to: 
Veening et al. (1984); Aggleton, (2000); Kjelstrup et al. (2002); Sah et al. (2003); 
LeDoux, (2007); Ehrlich et al. (2009); Walker et al. (2009); Morozov et al. (2011); Tye 
et al. (2011); Mahan and Ressler, (2012); Pare and Duvarci, (2012). 
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Regarding neurotransmission, glutamate and gamma-aminobutyric acid (GABA) 
exert their effects within this circuitry via the activation of their respective ionotropic 
and metabotropic receptors (Sah et al., 2003). 
It is important to mention that the computational properties of the amygdalar system 
with respect to input-output relationships on the level of neuronal network activity and 
plasticity are difficult to resolve due to the incomplete knowledge about the functional 
connectivity. Some studies have linked the activity within distinct amygdalar key 
nuclei with behaviour related to fear and anxiety. For example the optogenetic control 
of distinct central amygdalar nuclei revealed that the lCe is involved in the acquisition 
of fear memory, whereas the mCe in its behavioural expression (Ciocchi et al., 2010).   
Transgenic mice carrying a construct, in which a reporter gene (β-galactosidase) was 
under the control of the c-fos promoter, demonstrated that a population of 
glutamatergic neurons in the LA is activated by contextual fear conditioning (Wilson 
and Murphy, 2009). Other studies using in vivo single unit recordings in rats showed 
that after auditory fear conditioning the presentation of the CS was capable of 
increasing the firing rate of LA projection neurons. This phenomenon was 
accompanied by freezing behaviour (Repa et al., 2001; Goosens et al., 2003). 
By use of a fear conditioning paradigm in rats, a contextual cue was employed as a 
CS. The authors observed that after CS-US pairing the neuronal activity increased 
upon CS presentation, and that the animals exhibited freezing behaviour (An et al., 
2012).  
Another study demonstrated that the anxiogenic drug yohimbine was capable of 
increasing the spontaneous activity of projection neurons in the BLA, as revealed by 
in vivo recordings in rat brains (Buffalari and Grace, 2009). This finding is in line with 
a report showing that the optogenetic activation of BLA projection neurons of mice, 
which terminate in the ventral hippocampus, enhances anxiety-related behaviour 
(Felix-Ortiz et al., 2013). Conversely, it was also shown that optogenetic activation of 
a subpopulation of principal neurons in the BLA of mice exerts an inhibitory influence 
on the activity of neurons in the mCe and LA. This activation resulted in a decreased 
fear response of these animals during an auditory fear conditioning paradigm 
(Jasnow et al., 2013).   
Taking together, it is likely that an increase in neuronal activity within the LA can be 
related to anxiety, fear, and fear memory, whereas the activity in the BLA might 
differentially contribute to distinct forms of anxiety, fear, and fear memory. 
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In the following part, cellular mechanisms, potentially involved in the modulation of 
neuronal network activity and plasticity in the LA and BLA will be described. 
  
1.5.3.1 Neuronal plasticity 
 
Neurons and consequently neuronal networks exhibit the potential to undergo long 
lasting changes of their firing properties in response to certain stimuli, a phenomenon 
that is mediated by a structural remodelling of the cellular architecture. The resultant 
physiological changes can be seen as an adaptation to changing environments (Ho 
et al., 2011). With respect to the fear conditioning paradigm, the CS-US association 
is thought to be partially stored in the LA and BLA (Myers and Davis, 2007; Johansen 
et al., 2010). Extinction training after fear conditioning can weaken the acquired 
memory traces in these nuclei. From a functional point of view, this effect most likely 
results from the formation of new memories (Orsini and Maren, 2012). 
Cellular mechanisms which are thought to mediate long-lasting changes in neuronal 
activity that accompanies fear memory formation or extinction is long-term 
potentiation (LTP) or long-term depression (LTD). LTP is a lasting increase in the 
strength of synaptic transmission, LTD a lasting decrease (McKernan and Shinnick-
Gallagher, 1997; Rogan et al., 1997; Sigurdsson et al., 2007; Orsini and Maren, 
2012). 
 
Plasticity in the LA and BLA 
 
Sensory inputs conveyed by thalamic and cortical afferences to LA and BLA neurons 
about CS and US are able to induce a lasting enhancement in the strength of 
synaptic transmission and, thereby, to increase the strength of neuronal activity 
(McGaugh, 2004; Sigurdsson et al., 2007; Orsini and Maren, 2012). In vivo studies in 
rats showed that the infusion of D(-)-2-Amino-5-phosphopentanoic acid (AP 5), a N-
methly-D-aspartate (NMDA) receptor antagonist, into the amygdala, blocked the 
acquisition of fear memory, which is in line with the observation that activity of this 
ionotropic glutamate receptor is frequently essential for LTP induction (Miserendino 
et al., 1990; Collingridge and Bliss, 1995; Hille, 2001). NMDA receptors are calcium 
permeable channels, activated by the binding of glutamate but blocked at resting 
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membrane potential by magnesium. This Mg2+ block is removed upon depolarization 
which allows the influx of calcium ions into the postsynapse (Hille, 2001).  
It has been shown that the composition of NMDA receptor subunits in principal 
neurons of the LA varies between synapses depending on their cortical or subcortical 
origin (Weisskopf and LeDoux, 1999). These differences can be related to different 
responses upon plasticity-inducing stimuli: GluN2A-containing NMDA receptors are 
involved in the induction of LTP whereas GluN2B-containing receptors in the 
mediation of LTD (Dalton et al., 2012). On the behavioural level, a blockade of 
GluN2B receptors in the amygdala impairs extinction of conditioned fear in rats 
(Dalton et al., 2008).  
The LA and BLA also display other forms of plasticity. An example for this is the 
involvement of voltage-gated calcium channels (VGCCs). It was shown, both in vivo 
and in vitro, that interfering with calcium signalling via the application of calcium 
chelators or blockers of VGCCs impaired fear memory formation and induction of 
LTP, respectively (Orsini and Maren, 2012). The specific involvement of L-type 
VGCCs (L-VGCCs) in fear extinction was demonstrated by the infusion of the 
antagonists verapamil or nifedipine into the BLA of rats (Davis and Bauer, 2012). The 
downstream targets of NMDA receptor and L-VGCC activation is the regulation of 
intracellular calcium concentration which, in turn, modulates a variety of signalling 
cascades (Blair et al., 2001). These include: NO-synthase, phosphatases, protein 
kinase A (PKA), protein kinase B (PKB), protein kinase C (PKC), calcium/calmodulin 
protein kinase (CaMKII), mitogen-activated protein kinases (MAP Kinases), IP3-
signalling. Synaptic changes primarily occur on the level of exo- and endocytosis and 
trafficking of α-amino-3-hydroxy-5-methly-4-isoxazolepropionic acid (AMPA) 
receptors. Other mechanisms include: presynaptic vesicle mobilization and 
stabilisation of the synapse through adhesion molecules (e.g. neural cell adhesion 
molecules) (Lin et al., 2001; Ho et al., 2011; Johansen et al., 2011; Orsini and Maren, 
2012).  
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1.5.3.2 Mediators of the stress responses and their influence on neuronal 
network activity and plasticity in the LA and BLA 
 
CRH 
 
CRH, a 41 amino-acid long peptide, is a fast mediator of the stress responses within 
HPA axis regulation (Refojo and Holsboer, 2009). CRH is also involved in the 
regulation of fear and anxiety behaviour (Roozendaal et al., 2002; van Gaalen et al., 
2002; Shekhar et al., 2005; Gallagher et al., 2008; Hostetler and Ryabinin, 2013). 
Besides in the PVN, CRH is also produced in the CeA and is capable of invading the 
LA and BLA upon its release (Roozendaal et al., 2002; Shekhar et al., 2005). 
Within the brain of humans and rodents two classes of CRH receptors (CRHR1 & 
CRHR2) can be found in basal forebrain and brainstem circuits (Gallagher et al., 
2008). These G-protein-coupled receptors exert various intracellular effects including 
the increase of cyclic adenosine monophosphate (cAMP) and free calcium as well as 
the regulation of the activity of PKA, PKB, PKC and MAP Kinases (Gallagher et al., 
2008). CRHR1 messenger RNA (mRNA) is detectable in the LA and BLA, and its 
expression has been shown to influence anxiety-related behaviour (Refojo et al., 
2011). In another in vivo study performed in rats, the authors could demonstrate that 
infusions of CRH into the LA enhance the expression of conditioned fear and 
attenuate fear memory formation (Isogawa et al., 2013). Roozendal et al. (2008) 
showed that CRH infusions into the rat BLA facilitate memory consolidation via 
retention of inhibitory avoidance performance. 
In a study conducted in mouse brain slices, the authors found that bath application of 
CRH strengthened signal propagation from the LA to the BLA via CRHR1 (Refojo et 
al., 2011). 
 
Corticosteroids 
 
Corticosteroids such as Cort are produced by the adrenal glands and released into 
the blood in a high extend during stressful events. They can cross the blood-brain 
barrier and affect distinct brain functions via binding to mineralocorticoid (MRs) and 
glucocorticoid (GRs) receptors (Fink, 2006). GRs exert their actions via genomic and 
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non-genomic effects. On the genomic level, the ligand-receptor complex in the 
cytoplasm translocates into the nucleus and acts as a transcription factor (Makara 
and Haller, 2001; Groeneweg et al., 2012). Three criteria have been defined to 
separate genomic from non-genomic effects: onset of the effect, independence of 
blockade of parts of the receptor complex, and endurance of the effect after the 
elimination of putative genomic targets (Makara and Haller, 2001). 
Membrane-bound MRs and GRs are found in the amygdala of mice and rats, with 
their highest density nearby synapses, thus suggesting that they exert fast, non-
genomic effects (Johnson et al., 2005; Groeneweg et al., 2012). Downstream of 
corticosteroid binding, signalling factors that were shown to be involved in mediating 
such effects include extracellular signal-regulated kinase (ERK1/2), G-proteins, 
cAMP, PKA, CREB, intracellular calcium concentration changes and phospholipase 
C (PLC). These findings originate from studies done in the hippocampus, 
hypothalamus, and dorsal root ganglion cell culture (Groeneweg et al., 2012). 
An in vivo study in rats investigating the influence of Cort on the retention of 
contextual fear memory showed that this treatment increases freezing behaviour up 
to 6 days after conditioning (Thompson et al., 2004). With respect to neuronal 
activity, it has been shown in brain slices from rats that application of Cort enhances 
the excitability of BLA projection neurons by a decrease of GABAergic inhibition onto 
these neurons. This effect was mediated by a shift of the Cl- reversal potential 
(Duvarci and Pare, 2007). Another in vitro study using mouse brain slices 
demonstrated a rapid, MR-dependent increase of excitatory postsynaptic currents in 
the BLA upon application of Cort (Karst et al., 2010). 
 
 
1.5.3.3 Pharmacological intervention  
 
An important question arising from the observation that an increase in neuronal 
activity in the LA and partly in the BLA is linked to anxiety is whether pharmacological 
intervention can counteract this phenomenon (Maren and Quirk, 2004). One 
commonly used and, from a mechanistic point of view, well understood class of 
chemical compounds are benzodiazepines such as diazepam (Whiting, 2006). This 
positive allosteric modulator of the GABAA receptor is well suited for the treatment of 
pathological anxiety, as the regulation of excitation in the LA and BLA is mediated via 
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GABAA receptors (Sah et al., 2003). In spite of this beneficial effect, the use of 
benzodiazepines is accompanied by severe side effects, which include cognitive 
impairment and the risk of addiction (Whiting, 2006). Out of these constraints, other 
interventions are also indicated for the treatment of anxiety disorders and novel 
substances are under development. A putative novel pharmaceutical, namely N-(4-
Hydroxyphenyl) arachidonylamide (AM 404), is based on the fact that the regulation 
of emotional processing, such as extinction of fear memories, is affected by the 
endocannabinoids anandamide and 2-arachidonoyl glycerol. These molecules bind 
to two receptors, from which cannabinoid receptor type 1 is the most widely 
expressed in the brain (McDonald and Mascagni, 2001). Upon binding, 
endocannabinoids affect excitatory and inhibitory neurotransmission. In the context of 
fear conditioning, endocannabinoids facilitate extinction of fear memory (de 
Bitencourt et al., 2013; Mechoulam and Parker, 2013). Accordingly, it was shown that 
AM 404, which acts as an inhibitor of endocannabinoid uptake, facilitates the 
extinction of contextual fear memories in rats (de Bitencourt et al., 2008). 
In the currently available pharmacotherapy selective serotonin reuptake inhibitors 
(SSRIs), serotonin noradrenalin reuptake inhibitors (SNRIs), and tricyclic 
antidepressants (TCAs) are also indicated for the treatment of various anxiety 
disorders (Zohar and Westenberg, 2000; Vaswani et al., 2003; Katzman, 2004; 
Benkert and Hippius, 2011). From a functional point of view, it could be shown that 
chronic treatment with the SSRI citalopram impaired fear extinction. This effect was 
accompanied by a downregulation of the GluN2A subunit of the NMDA receptor 
(Burghardt et al., 2013). Another in vitro study revealed that the SSRI tianeptine was 
capable of reducing the firing frequency of action potentials of LA neurons. As shown 
in vivo, tianeptine treatment also prevented the stress-mediated increase in dendritic 
outgrowth in the LA and anxiety-like behaviour (Pillai et al., 2012).  
It is increasingly thought, that distinct SSRIs exert an anxiolytic effect via the 
modulation of glutamatergic neurotransmission in limbic circuits including the BLA 
(McEwen et al., 2010). Out of these observations, the question arises if the regulation 
of neuronal activity can be observed on a circuit level, thus providing a potential 
neuronal network mechanism by which distinct classes of antidepressants mediate 
parts of their anxiolytic effects.   
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1.6 Working hypothesis 
 
The heterogeneous neuronal networks of the LA and BLA are involved in the 
regulation of fear, fear memory and anxiety. This regulation is mediated by the 
modulation of signalling strength and several studies point towards a positive 
correlation between increased neuronal activity and fear, fear memory and anxiety. 
However, a gap of knowledge exists between the electrical activity of single neurons 
in the LA and BLA and the activity of the network as a whole processing unit, due to 
the incomplete knowledge regarding the underlying circuitry.  
An approach to partly bridge this knowledge gap is the investigation of whole 
neuronal network activity in brain slices, containing parts of clearly defined amygdalar 
nuclei. In this way, network activity and plasticity in the LA and BLA can be 
investigated, thereby capturing the sum of cellular events in response to certain 
stimuli, reflected by alterations in signalling strength.  
To achieve this, an assay was developed, based on voltage-sensitive dye imaging 
(VSDI). This technique is capable of reporting changes in neuronal activity and 
plasticity with a high spatial and temporal resolution (Airan et al., 2007; Stepan et al., 
2012).  
Questions addressed in the present work 
 
1. Is it possible to reliably investigate neuronal activity in brain slices containing 
    distinct nuclei of the amygdala by use of VSDI? 
2. Is it possible to monitor amygdalar neuronal network plasticity with VSDI?  
3. Is it possible to increase the capacity of detection in the recorded VSDI signals to 
    quantitatively and reliably capture plastic changes as response to certain stimuli? 
4. Which receptors and ion channels are involved in mediating the putative changes?    
5. Do mediators of the stress responses impact on neuronal network activity and 
    plasticity in the LA and BLA? 
    5.1. Involvement of CRH? 
    5.2. Involvement of Cort? 
6. Do brain slices from HAB/NAB mice differ in amygdalar neuronal network  
    plasticity? 
7. Are pharmaceutical components capable of influencing amygdalar neuronal   
    network activity monitored by VSDI? 
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2 Material and Methods 
 
2.1 Mice 
 
Horizontal brain slices were prepared from 8-12 weeks old male C57BL/6N male 
mice (Bl 6) (Animal breeding facility MPI of Neurobiology), CD 1 male HAB mice, CD 
1 NAB mice (line maintenance at the MPI of Psychiatry) or male Crhr1loxP/loxP 
Camk2α-Cre (CKO) and male Crhr1loxP/loxP (CTRL) mice (housed at the MPI of 
Psychiatry). All mice were housed under standard laboratory conditions (light cycle 
12:12 hours), room temperature (22°C), air humidity (55%) with food and water ad 
libitum. Animals of the same sex were housed and kept together in groups of 3-5 
animals. All experiments were performed in accordance with governmental 
guidelines for animal welfare of Upper Bavaria, Germany.  
CKO and CTRL mice were provided by the research group Molecular Neurogenetics 
of the MPI of Psychiatry; for details, see Refojo et al. (2011). In brief: for generation 
of mice with a conditional Crhr1 allele, animals were created using in utero 
electroporation of a modified Crhr1 allele carried by a linearized vector within TBV2 
embryonic stem cells from 129S2 mice (Kühne et al., 2012) . The mice carrying a 
Crhr1loxP/loxP allele were backcrossed for seven generations to Bl 6 mice. Generation 
of mice in which the Crhr1 allele was selectively deleted in forebrain glutamatergic 
neurons was achieved by crossing Crhr1loxP/loxP mice with Crhr1loxP/loxP Camk2α-Cre 
mice (Minichiello et al., 1999), which were backcrossed with Bl 6 mice for more than 
10 generations. 
CD 1 HAB/NAB mice were provided by the research group Behavioural 
Neuroendocrinology of the MPI of Psychiatry. In brief: these mouse strains were 
selected and bidirectional bred with respect to their behavioural phenotype regarding 
their time spent on the open arms in the elevated plus-maze paradigm (Krömer et al., 
2005).  
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2.2 Preparation of brain slices 
 
The animals were sacrificed and decapitated. The following steps were conducted in 
ice-cold sucrose-based artificial cerebrospinal fluid (sACSF) saturated with carbogen 
gas (95% O2 / 5% CO2). The sACSF (pH 7.4) contained the following (in mM): 87 
NaCl, 2.5 KCl, 1.25 NaH2PO4, 25 NaHCO3, 25 glucose, 75 sucrose, 7 MgCl2, 0.5 
CaCl2. After decapitation the brain was quickly removed and separated into its 
hemispheres. For this, the scalp was removed with a scissor to expose the scull. A 
cut along the midline from caudal to rostral was made with a scissor and the halves 
of the cranium were opened with a pincer. The brain was hauled out using a rounded 
spatula after cutting the optical nerve. After preparation the brain was put in ice-cold, 
carbogenated sACSF for at least 1 min. Subsequently, the whole brain was 
transferred onto a sACSF saturated filter (Whatman) to trim the brain for the slicing 
procedure with a razor blade. This included cutting off of the cerebellum and the 
olfactory bulb. The brain was separated into its hemispheres by cutting along the 
midline and one hemisphere was afterwards put onto its cut face. The other 
hemisphere was stored in sACSF. A transversal cut was made at the dorsal part of 
one hemisphere resulting in a cut face on which the brain was glued on the vibratom 
holder using histoacrly glue (Braun, Aesculap). Horizontal brain slices with a 
thickness of 400 µm containing distinct nuclei of the amygdala were prepared using a 
vibratom (Microm, HM 650 V). To preserve a similar amygdaloid network among the 
slices, landmarks were used (see results). After slicing, the slices were kept in a 
holding chamber containing carbogenated sACSF for 30 min at 34ºC. After this 
incubation, slices were transferred into a holding chamber containing carbogenated 
ACSF which was composed of (in mM): 125 NaCl, 2.5 KCl, 1.25 NaH2PO4, 25 
Glucose, 25 NaHCO3, 1 MgCl2, 2 CaCl2 (pH 7.4) (nACSF) and incubated at room 
temperature (22-25°C; RT). 
For extracellular recordings, the slices were incubated for at least 1.5 hours in 
nACSF at RT.  
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2.3 VSDI 
 
For staining, the voltage-sensitive dye (VSD) 4-(2-(6-(Dibutylamino)-2-naphtalenyl)-1-
(3-sulfopropyl) pyridinium hydroxide inner salt (Di-4-ANEPPS) (dissolved in dry 
Dimethlysulfoxide (DMSO) to a 20.8 mM stock solution) was used. The slices were 
placed in a staining chamber which contained carbogenated nACSF and Di-4-
ANEPPS (7.5 µg/ml; <0.1% DMSO) for 15 min at RT. After the staining procedure, 
the slices were incubated for at least 30 min in a carbogenated nACSF containing 
holding chamber at RT. 
For VSDI experiments the slices were placed in the recording chamber and 
continuously superfused with carbogenated nACSF (3 ml/min flow rate) using a 
gravity perfusion system and a peristaltic pump (Ismatec). To fix the slice in the 
recording chamber, a grid consisting out of a platinum frame on which nylon strings 
were glued was put onto the slice.  
To evoke neuronal activity within the LA and BLA, square pulse electrical stimuli (200 
µs pulse width) were delivered via a custom made monopolar tungsten electrode 
(Science Products; 50 µm pole diameter) to either the EC or intra-nuclear fibres of 
the LA using an Iso-Stim 0.1M stimulator (npi). The stimulation electrode was 
positioned onto the slice using a micro manipulator. The stimulator was triggered by 
the MiCAM02 software via an A/D converter.  
VSDI was conducted using the MiCAM02 hard- and software package (Brain Vision, 
Tokyo, Japan). The tandem-lens microscope was equipped with the MiCAM02-HR 
camera and the 2x and 1x lens at the objective and condensing side, respectively. 
For excitation of Di-4-ANEPPS, a halogen lamp (Moritex, MHAB-150W) was used 
and its light was band-pass filtered at a wavelength of 530 nm. Emitted light was 
high-pass filtered (>590 nm) and captured via a charged-coupled device (CCD) 
camera (Figure 2.3-4). 
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Figure 2.3-4. Principle of VSDI. VSDI = Voltage-sensitive dye imaging, adapted from Tominaga et al. (2000)
 
Acquisition parameters were 88 x 60 pixels frame size, 36.4 x 40 µm pixel size and 
2.2 ms sampling time. 
For noise reduction, four acquisitions of an interval of 5 sec were averaged. This step 
was done in all VSDI recordings. Additionally, three acquisitions, averaged as stated 
above, were taken at an interval of 2 min and subsequently averaged (Figure 2.3-5). 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3-5. Data acquisition using the Brain Vision software  and averaging steps to reduce noise.
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For processing of averaged VSDI data, the relative change in fluorescence intensity 
ΔF/F was calculated per pixel. Spatial and temporal smoothing was conducted by 
applying a 3x3x3 average filter. Quantification of VSDI signals was done using the 
peak of "Region of interest" (ROI)-extracted fast-depolarization mediated imaging 
signals (FDSs) after stimulus onset.  
To minimize calculation errors due to noise, a ΔF/F value before stimulus onset was 
subtracted from the value of the FDS peak amplitude (Figure 2.3-6). 
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Figure 2.3-6. Baseline correction of FDSs. The average value of noise-induced baseline fluctuations before stimulus onset
during a timeframe of 4.4 ms (green bar) is subtracted from the FDS value of the FDS peak amplitude to determine the
change in fluorescence induced by electrical stimulation (red arrow).
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Recordings were made after adjusting the peak amplitude of FDSs extracted by ROIs 
covering either the LA or the BLA to the half-maximum amplitude as exemplified in 
Figure 2.3-7. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3-7. Principle of the adjustment of FDSs for subsequent VSDI experiments in the LA and BLA. For all VSDI
experiments, the stimulation intensity was adjusted to reach the half-maximum amplitude of the FDS within the LA- or BLA-
ROI. LA = Lateral amygdala, BLA = Basolateral amygdala, FDS = Fast depolarization-mediated signal, ROI = Region of
interest, VSDI = Voltage-sensitive dye imaging.
 
 
Although ΔF/F values differed among slices, a stimulation intensity of ~16 V to reach 
saturation of the FDS amplitude was the same throughout slices. If a slice could not 
be saturated within this range, it was excluded from subsequent analysis. After 
obtaining stable baseline responses, substances were bath applied for the 
investigation of their effect on FDS peak amplitude or plasticity. For induction of 
plastic changes within the LA or BLA, two trains of stimuli (100 Hz for 1 s; HFS) 
separated by a 30 s interval were applied to the EC using the same stimulation 
intensity as used for baseline recordings. For delivering HFS through the stimulator, it 
was triggered using a pulse generator (Master 8, A.M.P.I). 
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In the analysis, two parameters were used, which are defined as follows: 
 
Neuronal network activity 
Responses of the VSD-stained neuronal network upon single-pulse electrical 
stimulation 
 
Neuronal network dynamics 
Responses of the VSD-stained neuronal network upon single-pulse electrical 
stimulation after HFS 
 
For the investigation of network activity, reflected by the FDS amplitude, a ROI was 
set manually according to anatomical landmarks and quantification of VSDI signals 
was done using the Brain Vision Software by averaging all ΔF/F values of the pixels 
within the ROI. This was done for baseline movies and movies which were acquired 
after application of a particular substance. All values were normalized to baseline and 
statistical analysis was conducted by comparing the average values of the last three 
datapoints after substance application or HFS to baseline. Network dynamics were 
investigated by data processing in Matlab (Matlab & Simulink, Version: R2007b; The 
Mathworks 2007). For this purpose, Brain Vision-processed VSDI movies were 
exported as ASCII files and subsequently imported into Matlab.  
 
2.4 Advanced data processing  
 
Initial Processing 
 
By the import of ASCII files into Matlab, 80x66 pixeld arrays, which contained the 
inverted differential data of Brain Vision images, were created. Specific frames from 
single Brain Vision movies were preselected in the Brain Vision software to be 
exported. 
To assess the background noise, the last 20 frames before electrical stimulation were 
selected. The root-mean square (RMS) noise throughout these 20 consecutive 
frames was calculated per pixel by using: 
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As threshold operation, the threefold value of RMS values was used for further 
processing. These operations were done over three movies and the resulting values 
for each pixel were averaged across these movies. In the following, this array, which 
contained the averaged threefold RMS values per pixel across three movies, is 
termed "RMSThreshold". These values corresponded to the approximately three-fold 
value of the standard deviation of the background noise at a particular pixel. The 
RMSThreshold was used to reliable distinguish between sites which display a 
stimulation induced depolarization before HFS and sites within the movies, only 
exhibiting noise. For this purpose 25 frames, which were acquired directly after 
stimulus onset, were extracted from the baseline movies. To compensate for noise, 
the frame before stimulus onset was extracted and its single-pixel values were 
subtracted from the corresponding pixel values of post-stimulus frames. Afterwards, 
a maximum intensity projection over all frames was computed to capture the FDS. 
The resultant array contained the maximum single-pixel values of ΔF/F with a time 
period of 55 ms after stimulus onset (see results, Figure 3.2.2-16). Maximum single 
pixel values which displayed a value >RMSTreshold were set to 1, whereas pixels 
with values ≤RMSTreshold were set to 0. All baseline movies were processed in this 
way and as a final step multiplied by each other. The resultant array was used as an 
"Active Site Filter", new designed for each slice (see results, Figure 3.2.2-15, Figure 
3.2.2-14C). By multiplication of the Active Site Filter with the corresponding arrays of 
the movies, pixels, to be further processed were selected. 
For the analysis of network dynamics within a particular slice, 25 frames after 
stimulus onset were extracted from the baseline movies and all movies after HFS, 
and processed for baseline fluctuations and maximum intensity to capture the FDS 
over time. The Active Site Filter was applied to all of these arrays. Afterwards, 
baseline arrays were averaged and all arrays were divided by this array. This 
resulted in arrays which contain the relative changes in network response before and 
after HFS over all active sites across the maximum change of ΔF/F over time. The 
resulting spatial resolution corresponded to the distance of the single light sensors in 
the CCD camera; i.e. 36.4 x 40 µm (see results, Figure 3.2.2-14D, E).  
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To restrict single-pixel values to the LA or BLA, ROIs were set according to 
anatomical landmarks. Array values within the LA or BLA were set to 1 whereas all 
values outside the LA or BLA were set to 0. The resultant array was multiplied with all 
processed arrays. 
 
Value Extraction 
 
To reliably detect only sites, which either displayed potentiation or depression of 
neuronal activity after HFS, filters were designed. The parameter to define 
continuous potentiation or depression at one site was its persistence between 
minutes 30 and 42 after HFS. Therefore, pixels which showed a potentiation or a 
depression with respect to ΔF/F that lasted over the last three processed movies 
were used for subsequent analysis. 
Both filters were designed in a two-step procedure. For filtering of continuously 
potentiated sites, all single pixel values ≤1 were set to 0, whereas those exhibiting a 
value >1 were set to 1. This was done for the last three arrays of ΔF/F, thereby 
spanning the time period of minutes 30-42 after HFS. The three resultant arrays were 
multiplied by each other, creating an array that served as filter to detect potentiated 
sites over time. This filter in turn was multiplied with all processed arrays and only 
sites, which were included in the resultant arrays, were termed sites where 
potentiation occurred. 
The same procedure was carried out for sites of depression, with exception of the 
initial two steps. In the first step, all single pixels that showed a value ≥1 were set to 
0. After that, all pixels displaying a value >0 were set to 1. 
If these filters were applied and a slice did not show sites of continuous potentiation 
or depression, it was excluded from some of the following extraction steps. 
The extraction of several parameters was done after the processing steps. This 
included the extraction and averaging of relative values of all potentiated or 
depressed sites. Additionally the number of potentiated or depressed sites was 
quantified. To take into account both the strength of plasticity and the number of 
plastic sites, the total strength of all potentiated or depressed sites was determined 
by summing up the single percentage values of potentiation or depression.  
If a slice did not show continuous potentiation or depression, the number of 
potentiated or depressed sites was defined as zero. For the other two analysis 
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parameters, values of relative change or total change were excluded from further 
analysis. 
For the analysis of network dynamics in the BLA, only parameters of potentiation 
were analysed. 
 
2.5 Field potential recordings 
 
For field potential recordings, slices were transferred to the recording chamber 
mounted on a vibration-cushioned table (TMC, Peabody). The slices were 
continuously superfused with carbogenated nACSF. All devices were grounded and 
the setup was located within a faraday cage (TMC, Peabody) to minimize electric 
noise. Slices were fixed by means of a grid and the stimulation electrodes, as well as 
the recording electrode, were positioned into the neuronal tissue using 
micromanipulators (PCS 400, EXFO, Burleigh). The recording electrodes had an 
open-tip resistance of 0.8-1.1 MΩ. The electrodes were pulled from borosilicate glass 
capillaries (GC 150TF-10 (Harvard Apparatus)) using DMZ Universal puller (Zeitz) 
and filled with nACSF. Square pulse electrical stimuli (50 µs pulse width) were 
applied using the Iso-Stim 0,1M stimulator (npi). The Master 8 stimulator was used to 
trigger the stimulator to apply HFS. For single-pulse electrical stimulation and 
recording of signals at an interval of 15 s, the Pulse 8 software (HEKA Electronic) 
was used to trigger the stimulator through an A/D converter (HEKA Electronic). 
Signals were low-pass filtered at 1 kHz and sampled at 5 kHz.  
Since the signals recorded within the LA can reflect both excitatory field postsynaptic 
potentials and action potentials, the peak amplitude of the potential deflection was 
used as quantitative of activity instead of the slope (Kulisch et al., 2011). 
Recordings were performed in the LA upon stimulation of the EC. Baseline field 
potential responses were adjusted to half maximum of the field potential amplitude 
and after obtaining stable responses over 20 min, HFS was applied. The responses 
after HFS were recorded for 45 min. 
The maximum field potential amplitude was analysed using the Pulse 8 software. 
Afterwards, 4 recordings were averaged to 1 data point. Recordings were normalized 
to baseline responses. 
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Chemicals 
 
Substances were diluted and applied via the perfusion system or diluted in the 
staining chamber for VSDI staining. In all cases in which chemicals were solved in 
DMSO, the same amount of DMSO was added to the nACSF for baseline recordings.  
For details regarding chemicals, see appendix 1. 
 
Statistics 
 
All values are given as mean ± SEM. Statistical analysis was performed using the 
two-tailed unpaired/paired t-test, the Mann-Whitney Rank Sum test, the Wilcoxon 
Signed Rank test, the One-Way ANOVA followed by Bonferroni post hoc test or the 
One-Way ANOVA on ranks followed by Dunn's test. Data were tested on ranks as 
stated above, if the respective normality or equal variance test failed. 
Data sets were tested using the Grubb's test with a p-value of 0.05 for significant 
outlyers. Differences were considered significant if p < 0.05 (*p < 0.05, **p < 0.01, 
***p < 0.001).  
Statistical analysis was done by use of Sigma Stat or Graph pad Quickcalcs, which 
was accessed via: www.graphpad.com/quickcalcs/Grubbs1.cfm 
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3 Results 
 
3.1 Development of VSDI assay 
 
Slicing protocol and pharmacological characterization of VSDI signals 
   
Unless otherwise stated, in the following, brain slices from Bl 6 mice were used for 
experiments. For the investigation of network activity and dynamics within the LA and 
BLA, 400 µm-thick horizontal brain slices were cut. To obtain reliable and 
comparable results in all slices, a slicing protocol was developed according to 
anatomical landmarks. These landmarks included the lateral ventricle, the stria 
terminalis, and the CA1 region of the hippocampus. Since slicing was performed from 
ventral to dorsal, the pyramidal cell layer of the hippocampal CA1 region appeared 
diffuse at the level which contains the relevant neuronal network of the LA and BLA, 
marking the transition zone from the intermediate to the dorsal part of the 
hippocampus (Figure 3.1-8A). Additionally, a fibre bundle could be observed at the 
border from the BLA to CeA which has been described previously (von Bohlen und 
Halbach and Albrecht, 1998; Paxinos, 2004). The neuronal network contained in this 
slice preparation was used for all experiments. 
Subsequent slicing in a thickness of 400 µm resulted in a plane in which the 
pyramidal cell layer of the CA1 region was clearly defined, thus providing an end 
point for slice preparation (Figure 3.1-8B). As a reference for landmarks described 
above, an anatomical tracing study in the rat brain was used (von Bohlen und 
Halbach and Albrecht, 1998). 
 
 
 
 
 
 
 
Figure 3.1-8. Different planes of horizontal brain slices which contain distinct nuclei of the amygdaloid complex. A,
Brain slice which contains the ventral lateral amygdala, the dorsal basolateral amygdala, and the central nucleus of the
amygdala. B, Brain slice which contains the lateral amygdala and the central amygdala. The planes of the slices were cut with a
transversal distance of 400 µm. Landmarks to distinguish between different levels are described in detail using arrows. LA =
Lateral amygdala, BLA = Basolateral amygdala, CeA = Central amygdala, Scale bar = 400 µm.
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After the development of this slicing protocol, signal propagation was qualitatively 
investigated after the delivery of a single electrical stimulation pulse to the EC (Figure 
3.1-9). Amygdalar neuronal network activity spread from the EC to the lateral and 
medial portion of LA, the BLA, and from the LA and BLA to the CeA as described 
previously (Sah et al., 2003; LeDoux, 2007; Pare and Duvarci, 2012). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1-9. Overview of amygdaloid nuclei contained in the horizontal brain slice and location of the
stimulation electrode. Time course of VSD signal propagation within the lateral, basolateral, and central nucleus of
the amygdala after electrical stimulation of the external capsule. Warmer colours (see colour bar) represent stronger
neuronal activity. LA = Lateral amygdala, BLA = Basolateral amygdala, CeA = Central amygdala, VSD = Voltage-
sensitive dye.
 
 
Intra-LA single-pulse electrical stimulation resulted in signal propagation from the LA 
to the dorsal part of the BLA and the CeA within the brain slice (Figure 3.1-10). This 
pathway of activity flow was previously described (Pare and Duvarci, 2012). 
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Figure 3.1-10. Overview of amygdaloid nuclei contained in the horizontal brain slice and location of the
stimulation electrode. Time course of VSD signal propagation within the lateral, basolateral, and central nucleus of the
amygdala after electrical stimulation within the lateral amygdala. LA = Lateral amygdala, BLA = Basolateral amygdala,
CeA = Central amygdala, VSD = Voltage-sensitive dye.
 
The quantification of acquired VSDI signals is done by setting a ROI according to 
anatomical landmarks as previously described in the LA or BLA subfield (Figure 3.1- 
11A). The VSD Di-4-ANEPPS is capable of reporting de- or hyperpolarizing changes 
in membrane potential as alterations in fluorescence (Tominaga et al., 2000). Given 
this fact, one could observe, that the VSD signals had different time courses if 
comparing the LA with the BLA (Figure 3.1-11B). The LA signal displayed a slow 
hyperpolarizing component, which could be abolished by bath application of the 
GABAB receptor antagonist (2S)-3-[[(1S)-1-(3,4-Dichlorophenly-)ethyl]amino-2-
hydroxypropyl](phenylmethyl)phosphinic acid hydrochloride (CGP 55845) (5 µM) 
(data not shown). This antagonist was also capable of prolonging the stimulus-
evoked depolarization-mediated VSD signal in the LA and BLA FDSs. 
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Figure 3.1-11. Detection of VSD signal in specific ROIs after single electrical stimulation of the external capsule. A,
Dotted lines depict whole LA ROI (black) and whole BLA ROI (red) contained in the brain slice. Dotted gray line indicates the
border between LA and BLA; Scale bar: 400 µm. B, Time course of VSD signal after single stimulus onset colour coded for the
LA (black) and the BLA (red). For further quantification of VSD signals the FDS is used. Please note the slow
hyperpolarization-mediated component in the LA signal and its absence in the BLA signal. VSD = Voltage-sensitive dye, ROI =
Region of interest, FDS = Fast depolarization-mediated signal, LA = Lateral amygdala, BLA = Basolateral amygdala.
 
To pharmacologically characterize the VSD signal in our slices, the FDS component 
of the signal was chosen and known blockers of ion channels were bath applied. The 
voltage-gated sodium channel blocker tetrodotoxine (TTX) (1 µM) was capable of 
abolishing the FDS, whereas 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline-
2,3-dione (NBQX) (5 µM) and AP 5 (50 µM), blockers of ionotropic glutamate 
receptors strongly reduced FDS amplitudes (Figure 3.1-12A, C), thereby proving the 
FDSs to be mostly mediated by glutamatergic synaptic transmission. Since it is also 
known that GABAergic transmission plays an important role in the regulation of 
network activity within the amygdaloid complex, bicuculline methiodide (BIM) (2 µM), 
a GABAA receptor antagonist, was bath-applied. This resulted in a strong increase in 
FDS amplitudes (Figure 3.1-12B). This observation is in line with previous findings 
(Wang et al., 2001). Additionally, the stability of the FDSs over time was assed 
(Figure 3.1-12D). 
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Figure 3.1-12. Pharmacological characterization of VSD signal in the LA. A, B, C, Pharmacological characterization of
FDS after obtaining stable baseline responses by either bath application of 1 µM TTX (3 slices/2 animals), 2 µM BIM (6
slices/3 animals) or 50 µM AP 5 and 5 µM NBQX (3 slices/3 animals). D, Prove of stability of FDS over stimulation time (7
slices/4 animals). Data are presented as means ± SEM. VSD = Voltage-sensitive dye, FDS = Fast depolarization-mediated
signal, TTX = Tetrodotoxin, AP 5 = D(−)-2-Amino-5-phosphonopentanoic acid, NBQX = 2,3-dihydroxy-6-nitro-7-sulfamoyl-
benzo[f]quinoxaline-2,3-dione, BIM = Bicuculline methiodide.
 
 
All characterizations were done for signals that arose in the LA and BLA (BLA data 
not shown). 
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3.2 Investigation of neuronal network dynamics 
 
3.2.1 Field potential recordings 
 
Prior to the investigation of neuronal network plasticity by means of VSDI, a 
stimulation protocol to induce LTP was validated for its usability in the amygdaloid 
network contained in the brain slices. The application of HFS to the EC induced LTP 
of excitatory field potentials recorded in the LA. The magnitude of LTP was significant 
(22.9, ± 0.4%, n = 6 slices/5 animals) compared to the last 10 min of baseline 
recordings (Figure 3.2.1-13).  
 
Time (min)
0 10 20 30 40 50 60 70
N
o
rm
a
li
z
e
d
 f
ie
ld
 p
o
te
n
ti
a
l 
a
m
p
li
tu
d
e
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
HFS
**
Single electrical stimulation
100 µV
10 ms
LA
Position of the stimulation
electrode 
Recording electrode
N
o
rm
a
li
z
e
d
 f
ie
ld
 p
o
te
n
ti
a
l 
a
m
p
li
tu
d
e
 
Figure 3.2.1-13. Extracellular field potential recordings of LA responses upon single-pulse electrical stimulation of
the EC before and after HFS. HFS significantly (paired t-test, p = 0.001) increased field potential amplitude within the LA in
horizontal brain slices (n= 6 slices/5 animals). Representative traces illustrate extracellular responses before (grey) and after
(black) HFS. The scheme on the top shows of the location of the stimulation and recording electrodes. LA = Lateral amygdala,
EC = External capsule, HFS = High-frequency stimulation.
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3.2.2 Monitoring of network dynamics by means of VSDI and subsequent data 
processing 
 
To capture all HFS-induced changes in neuronal network excitability in the brain 
slice, advanced data analysis was applied to VSDI. First, network potentiation in the 
LA after HFS was monitored using VSDI. This approach was capable of reporting 
lasting changes in network activity (Figure 3.2.2-14A, B). 
To gain more detailed insights into neuronal network dynamics, VSDI movies were 
imported into Matlab for further processing. Active Sites were defined (Figure 3.2.2- 
15) (for details see material and methods) and a ROI was set according to 
anatomical landmarks (Figure 3.2.2-14C). 
The resultant images displayed changes in evoked network activity after HFS with a 
spatial resolution of 36.4 x 40 µm. By means of this analysis, it was possible to show 
that the LA is able to respond to the same HFS in opposite ways, spatially 
segregated: thus some sites showed potentiation whereas some other showed 
depression of the relative change in fluorescence after HFS compared to baseline 
level (Figure 3.2.2-14D, E). By use of anatomical landmarks, as described before, the 
BLA network, contained in the brain slice could also be analysed in this way (data not 
shown). Since the BLA was located in close proximity to the stimulation electrode, 
the resultant intense electrical excitation of the neurons of the BLA, most likely 
overrides depression of neuronal excitability. Therefore, BLA network dynamics were 
solely examined with respect to potentiation. 
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Figure 3.2.2-14. Neuronal network plasticity in the LA monitored by means of VSDI and subsequent data processing. A,
Baseline response 22 ms after single-pulse stimulation. B, LA response 22 ms after single-pulse stimulation 36 min after HFS.
Circle indicates network potentiation after HFS. C, "Active Site Filter" calculated by applying the "RMSThreshold" (for details
see material and methods) to single-pixel maximum change in fluorescence of 25 consecutive frames after stimulus onset
before HFS. The ROI was set according to anatomical landmarks excluding the portion of the BLA contained in the slice. D,
Relative baseline responses of all active sites within the LA upon single-pulse electrical stimulation. E, Responses of all active
sites 36 min after HFS within the LA upon single-pulse electrical stimulation. Arrows indicate a site of depression (blue) or
potentiation (red) before and after HFS. Colour bar: relative change of ΔF/F. LA = Lateral amygdala, BLA = Basolateral
amygdala HFS = High-frequency stimulation, RMSThreshold = Root mean square threshold, ROI = Region of interest, VSDI =
Voltage-sensitive dye imaging.
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Figure 3.2.2-15. Principle of the design of the Active Site Filter. Maximum changes in ΔF/F after single-pulse electrical
stimulation can be distinguished from noise by use of the RMSThreshold operation. Sites with maximum ΔF/F values
≤RMSThreshold (black trace) are set to 0, whereas sites with maximum ΔF/F values >RMSThreshold (red trace) are set to 1.
RMSThreshold = Root mean square threshold.
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The FDS was captured through a maximum intensity projection operation of change 
in fluorescence within single sites over a defined course of frames (Figure 3.2.2-16). 
 
 
 
 
 
 
 
 
 
 
Figure 3.2.2-16. Visualization of maximum intensity projection command output. A,B,C, Time course of changes in
fluorescence per pixel within the lateral amygdala shown for three different time points after single-pulse stimulation of the external
capsule. D, Maximum intensity projection map of ΔF/F values for each single pixel within 25 consecutive frames (Interval: 2.2 ms)
after stimulus onset. Colour bar: changes in fluorescence intensity relative to background. E, Time course of FDSs after delivering
a single electrical stimulation to the external capsule. Two traces depict different time courses of FDSs, dependent on the location
of the ROI, here exemplified through black and red squares. To reliably capture the maximum amplitude of the FDS within the
whole lateral amygdala within the slice, the maximum intensity projection map is computed in a certain time frame, illustrated by the
green bar. FDSs = Fast depolarization-mediated signals, ROI = Region of interest.
 
The network dynamics analysis of the LA offered the whole spectrum of parameters 
which could be extracted from the same slice (n = 10 slices/7 animals) (for details, 
see material and methods). In this way, it could be shown that, after HFS, VSD 
signals in the LA reliably reflected potentiation and depression of neuronal network 
activity on three levels. Mean values of relative strength of potentiation (15.7 ± 1.7%) 
or depression (15.9 ± 1.9%) were significant compared to baseline (Figure 3.2.2-
17A). Additionally, the sum of total strength of potentiation (1946 ± 515%) or 
depression (-1136 ± 229%) over all active sites which reliably displayed changes in 
activity was significant, compared to baseline activity at these sites (Figure 3.2.2-
17B). The third extracted parameter was the number of sites, in which potentiation 
(109 ± 22) or depression (69.9 ± 13.3) occurred (Figure 3.2.2-17C). 
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Figure 3.2.2-17. Changes in network dynamics within the LA after HFS in C57BL/6N mice. All measures were
extracted from the same slices (n = 10 slices/7 animals). A, Mean values of relative potentiation or depression of network
activity. Mean values of potentiation during minutes 30-42 after HFS showed significant increase compared to baseline
(paired t-test, p < 0.001). Mean values of depression during minutes 30-42 after HFS showed significant decrease
compared to baseline (paired t-test, p < 0.001). B, Mean values of total potentiation or depression of network activity. Mean
values of potentiation during minutes 30-42 after HFS showed significant increase compared to baseline (paired t-test, p =
0.004). Mean values of depression during minutes 30-42 after HFS showed significant decrease compared to baseline
(paired t-test, p < 0.001). C, Number of sites within the LA ROI which showed potentiation or depression of network activity
during minutes 30-42 after HFS. Data are presented as means  SEM. HFS = High-frequency stimulation, LA = Lateral
amygdala, LA ROI = Lateral amygdala region of interest.
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3.2.2.1 Pharmacological characterization of changes in network dynamics 
 
The observed changes in network dynamics were pharmacologic characterized using 
AP 5 as a NMDA receptor antagonist and verapamil, a blocker for L-VGCCs. NMDA 
receptors and VGCCs were previously shown to contribute to the induction of 
neuronal plasticity in the amygdala (Grover and Teyler, 1990; Huang and Kandel, 
1998; Bauer et al., 2002). 
After bath application of AP 5 (50 µM) or verapamil (50 µM) and after obtaining stable 
baseline responses, HFS was applied and its effect on network dynamics in the LA 
was investigated. 
The presence of verapamil significantly reduced the total strength of network 
potentiation (334 ± 73%, n = 9 slices/6 animals) in comparison to AP 5 treated slices 
(4820 ± 1096%, n = 10 slices/7 animals) (Figure 3.2.2.1-18A). Single-group 
comparison of the total strength in network potentiation of verapamil-treated slices 
with control slices (1946 ± 515%, n = 10 slices/7 animals) revealed that this treatment 
significantly (Mann-Whitney Rank Sum test, p = 0.002) reduced HFS-induced 
potentiation. In contrast to that, the presence of AP 5 significantly (t-test, p = 0.029) 
increased the strength of this parameter compared to control conditions. 
Concerning the HFS-induced total network depression, AP 5-treated slices exhibited 
a significant decrease (-288 ± 75%, n = 9 slices/7 animals) of network depression 
compared to slices which were bathed in verapamil-containing nACSF (-2938 ± 
424%, n = 8 slices/6 animals) (Figure 3.2.2.1-18B). Verapamil-treated slices showed 
a significant increase in strength of depression compared to control slices (-1136 ± 
229%, n = 10 slices/7 animals) (Figure 3.2.2.1-18B).  
Single-group comparison of HFS-induced total network depression between AP 5-
treated slices and control slices showed a significant (Mann-Whitney Rank Sum test, 
p = 0.006) decrease. 
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Figure 3.2.2.1-18. Effects of verapamil or AP 5 on LA network dynamics. A, The presence of 50 µM verapamil (open
circles) significantly (One-Way ANOVA on ranks, p < 0.001, followed by Dunn's test, p < 0.05) reduced the total strength of
network potentiation compared to 50 µM AP 5 (red circles). Black circles depict total strength of network potentiation in
untreated slices (verapamil: n = 9 slices/6 animals, AP 5: n = 10 slices/7 animals, control: n = 10 slices/7 animals). B, The
presence of 50 µM verapamil significantly (One-Way ANOVA, p < 0.001, followed by Bonferroni post hoc test, p < 0.001)
increased the total strength of network depression after HFS compared to AP 5-treated slices. 50 µM verapamil was capable of
significantly (One-Way ANOVA, p < 0.001, followed by Bonferroni post hoc test, p < 0.001) increasing the total strength of
network depression compared to controls (verapamil: n = 8 slices/6 animals, AP 5: n = 9 slices/7 animals, control: n = 10
slices/7 animals). Data are presented as means  SEM. AP 5 = D (−)-2-Amino-5-phosphonopentanoic acid, HFS = High-
frequency stimulation, LA = Lateral amygdala.
 
As stated before, BLA network dynamics were solely investigated regarding 
potentiation of activity. The comparison of total strength of potentiation between 
control slices (486 ± 125%, n = 10 slices/7 animals) with the presence of verapamil 
(158 ± 72%, n = 10 slices/6 animals) or AP 5 (620 ± 197%, n = 10 slices/7 animals) 
showed that there was no significant effect on this parameter (data not shown). 
However, 50 µM verapamil in the bathing solution significantly reduced the number of 
potentiated sites (4.70 ± 1.96, n = 10 slices/6 animals) compared to control condition 
(27.4 ± 5.9, n = 10 slices/7 animals) and AP 5-treatment (28.6 ± 8.8, n = 10 slices/7 
animals) (Figure 3.2.2.1-19). 
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Figure 3.2.2.1-19. Verapamil decreases the number of potentiated sites after HFS in the BLA. Bath application of
verapamil significantly (One-Way ANOVA on ranks, p = 0.005, followed by Dunn's test, p < 0.05) reduced the number of
potentiated sites after HFS comparing control conditions with the presence of verapamil and AP 5 conditions with the
presence of verapamil (verapamil: n = 10 slices/6 animals, AP 5: n = 10 slices/7 animals, control: n = 10 slices/7 animals).
Data are presented as means  SEM. BLA = Basolateral amygdala, HFS = High-frequency stimulation, AP 5 = D (−)-2-Amino-
5-phosphonopentanoic acid.
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3.2.3 Investigation of the effect of CRH on network activity and dynamics in the 
LA and BLA 
 
After the development of the VSDI assay for the examination of neuronal network 
activity and dynamics in the LA and BLA, the influence of mediators of stress 
response (CRH and Cort) on these electrophysiological measures was investigated. 
Based on studies which showed that neurons of the LA and BLA express functional 
CRHR1 and since the CeA is a major source of extra-hypothalamic CRH which is 
capable of entering the LA and the BLA (Roozendaal et al., 2002; Hubbard et al., 
2007; Refojo et al., 2011), the effects of CRH on neuronal network activity and 
plasticity were examined.     
Bath application of CRH (at the concentration of 125 or 250 nM) affected neuronal 
network activity reflected by changes in FDS amplitudes in the LA and BLA. Figure 
3.2.3-20A, C depicts the effect of bath application of 125 nM CRH on FDS 
amplitudes in the LA and BLA. Although 125 nM CRH increased the FDS amplitudes 
in the BLA, this effect was not statistical significant (6.60 ± 3.37%, n = 10 slices/7 
animals). Bath application of 250 nM CRH increased FDS amplitudes in the LA (3.20 
± 2.33%, n = 8 slices/5 animals) (Figure 3.2.3-20B), but again, this effect did not 
reach the level of significance. For statistical testing, the mean values of FDS 
amplitudes of the last 3 data points after CRH-application were compared to 
baseline. In contrast, the presence of 250 nM CRH in the bathing solution 
significantly increased FDS amplitudes in the BLA (6.50 ± 2.06%, n = 8 slices/5 
animals) (Figure 3.2.3-20D). 
 
 
 
 
 
 
 
 
 
 
3. Results                                                                                                                                               45 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2.3-20. Bath application of CRH affects FDS amplitudes in the LA and BLA in a concentration dependent
manner. A, C, Effects of 125 nM CRH on FDS amplitudes in the LA (A) and BLA (C). These effects did not reach the level of
significance. (n = 10 slices/7 animals). B, D, Effects of 250 nM CRH on FDS amplitudes in the LA (B) and BLA (D). Within in the
BLA, 250 nM CRH significantly (paired t-test, p = 0.016) increased FDS amplitudes (n = 8 slices/5 animals). Data are presented
as means  SEM. CRH = Corticotropin-releasing hormone, FDS = Fast depolarization-mediated signal, LA = Lateral amygdala,
BLA = Basolateral amygdala.
 
After obtaining stable baseline responses, HFS was applied in the same slices to 
investigate whether CRH affects network plasticity. In the LA, 125 nM CRH 
significantly increased the magnitude of HFS-induced relative potentiation (21.4 ± 
1.3%, n = 10 slices/7 animals) compared to untreated control slices (15.7 ± 1.7%, n = 
10 slices/7 animals) (Figure 3.2.3-21).  
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Figure 3.2.3-21. 125 nM CRH increases HFS-induced network plasticity in the LA. Bath application of 125 nM CRH
(open circles) significantly (unpaired t-test; p = 0.016) increased the magnitude of relative network potentiation compared to
control conditions (black circles) (control: n = 10 slices/7 animals, 125 nM CRH: n = 10 slices/7 animals). Data are presented
as means  SEM. CRH = Corticotropin-releasing hormone, HFS = High-frequency stimulation, LA = Lateral amygdala.
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In contrast, bath application CRH (250 nM) impacted HFS-induced changes in 
neuronal network dynamics in the LA on three levels. Compared to control conditions 
(109 ± 22, n = 10 slices/7 animals) and 125 nM CRH treatment (103 ± 14, n = 10 
slices/7 animals) the presence of 250 nM CRH significantly increased the number of 
potentiated sites (211 ± 22, n = 8 slices/5 animals) (Figure 3.2.3-22A). Moreover, 250 
nM CRH significantly reduced the number of depressed sites (16.3 ± 8.1, n = 8 
slices/5 animals) compared to control conditions (69.9 ± 13.3, n = 10 slices/7 
animals) (Figure 3.2.3-22B). Finally, the total strength of network potentiation was 
significantly enhanced (4102 ± 653%, n = 8 slices/5 animals) compared to control 
conditions (1946 ± 515%, n = 10 slices/7 animals) (Figure 3.2.3-22C). The 
comparison of the total strength of network potentiation in the presence of 125 nM 
CRH (2179 ± 317%, n = 10 slices/7 animals) with bathing solution containing 250 nM 
CRH (4103 ± 653%, n = 8 slices/5 animals) showed that there was a significant 
increase in total network potentiation (data not shown). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2.3-22. CRH-induced changes in network dynamics after HFS in the LA. A, The number of potentiated sites after HFS
was significantly increased in 250 nM CRH-treated slices compared to control slices (One-Way ANOVA, p = 0.001, followed by
Bonferroni post hoc test, p = 0.004) and 125 nM CRH-treated slices (One-Way ANOVA, p = 0.001, followed by Bonferroni post hoc
test, p = 0.002). B, The number of depressed sites after HFS was significantly decreased in 250 nM CRH-treated slices compared to
control slices (One-Way ANOVA, p = 0.011, followed by Bonferroni post hoc test, p = 0.010). C, Slices treated with 250 nM CRH (open
circles) exhibited a significant increase in HFS-induced total strength of network potentiation compared to control slices (black circles)
(One-Way ANOVA, p = 0.012, followed by Bonferroni post hoc test, p = 0.017) and to slices treated with 125 nM CRH (data not shown)
(One-Way ANOVA, p = 0.012, followed by Bonferroni post hoc test, p = 0.038) (control: n = 10 slices/7 animals, 125 nM CRH: n = 10
slices/7 animals, 250 nM CRH: n = 8 slices/5 animals). Data are presented as means  SEM and all statistical comparisons were done
for minutes 30-42 after HFS. LA = Lateral amygdala, HFS = High-frequency stimulation, CRH = Corticotropin-releasing hormone.
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The investigation of network dynamics in the BLA indicated that neither 125 nM (14.7 
± 3.8, n = 10 slices/7 animals) nor 250 nM (29.8 ± 3.9, n = 8 slices/5 animals) 
significantly altered the number of sites at which potentiation occurred (Figure 3.2.3-
23). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2.3-23. CRH induces no changes in the number of potentiated sites in the BLA after HFS. Bath application of
125 or 250 nM CRH did not significantly alter the number of potentiated sites after HFS (control: n = 10 slices/7 animals, 125
nM CRH: n = 10 slices/7 animals, 250 nM CRH: n = 8 slices/5 animals). Data are presented as means  SEM. BLA =
Basolateral amygdala, CRH = Corticotropin-releasing hormone, HFS = High-frequency stimulation.
 
 
 
3.2.3.1 Involvement of CRHR1 in CRH-induced changes in network activity and 
dynamics in the LA and BLA 
 
By use of CKO mice and CTRL mice, it was investigated whether CRHR1 is involved 
in the mediation of the observed changes in network activity and dynamics. Since 
CRH in the concentration of 250 nM influenced network activity or dynamics in the LA 
or BLA to the highest amount, this concentration was used for subsequent 
experiments. Bath application of 250 nM CRH to slices from CTRL mice increased 
FDS amplitudes in the LA (5.10 ± 2.63%, n = 10 slices/6 animals) (Figure 3.2.3.1-
24A). This effect did not reach the level of statistical significance. In contrast, 250 nM 
CRH significantly increased FDS amplitudes in the BLA (6.90 ± 2.75%, n = 9 slices/6 
animals) (Figure 3.2.3.1-24B). Subsequently, slices from CKO mice were treated with 
CRH and VSDI recordings were analysed in the same way. FDS amplitudes in the 
LA were not significantly altered by 250 nM CRH in the bathing solution (7.60 ± 
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6.96%, n = 7 slices/5 animals) (Figure 3.2.3.1-24C). However, the increase in FDS 
amplitudes induced by 250 nM CRH in the BLA was completely absent in brain slices 
from CKO mice (8.50 ± 8.98%, n = 7 slices/5 animals) (Figure 3.2.3.1-24D).  
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Figure 3.2.3.1-24. Effects of bath application of 250 nM CRH on FDSs in the LA and BLA in brain slices from CKO
and CTRL mice. A, Bath application of 250 nM CRH increased FDS amplitudes in the LA in CTRL mice. This effect did not
reach the level of significance (n = 10 slices/6 animals). B, In brain slices from CTRL mice (n = 9 slices/6 animals) 250 nM
CRH significantly (paired t-test, p = 0.016) increased FDS amplitudes in the BLA. C, 250 nM CRH had no significant effect on
FDSs in the LA using CKO mice (n = 7 slices/5 animals). D, The presence of 250 nM CRH in the bathing solution had no
significant effect on the FDS amplitudes in the BLA of CKO mice (n = 7 slices/5 animals). Data are presented as means  
SEM. CRH = Corticotropin-releasing hormone, FDS = Fast depolarization-mediated signal, LA = Lateral amygdala, BLA =
Basolateral amygdala, CTRL = Crhr1loxP/loxP mice, CKO = Crhr1loxP/loxP Camk2α-Cre mice.
 
For the investigation of network dynamics in the LA, 250 nM CRH was bath applied 
and after obtaining stable baseline responses HFS was delivered to the EC. 
In brain slices from CTRL mice, the presence of 250 nM CRH significantly increased 
the total strength of network potentiation (5024 ± 1263%, n = 10 slices/8 animals) 
compared to control conditions (1854 ± 588%, n = 8 slices/5 animals) (Figure 3.2.3.1-
25A). In the same slices, quantification of sites of potentiation revealed that CTRL 
mice, in the presence of CRH, displayed a significant increase in number (211 ± 38) 
compared to controls (97.4 ± 23.6) (Figure 3.2.3.1-25B). The decrease of depressed 
sites (control: 64.3 ± 10.0, 250 nM CRH: 34.7 ± 11.0) did not reach the level of 
significance (Figure 3.2.3.1-25C). 
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After these control experiments, CKO mice were used to investigate the role of 
CRHR1 in mediating the effects of CRH on network dynamics. With respect to the 
parameter total strength of network potentiation, there was no significant difference 
between the experiments performed in slices from CTRL (1854 ± 588%, n = 8 
slices/5 animals) and CKO mice (4415 ± 1742%, n = 9 slices/5 animals). On the level 
of strength of network potentiation, the same untreated slices from CKO mice did not 
significantly differ from slices treated with 250 nM CRH (5480 ± 1102%, n = 7 slices/5 
animals) (Figure 3.2.3.1-25D). Furthermore, quantification of the number of 
potentiated sites in the untreated slices (166 ± 48) vs. 250 nM CRH (237 ± 43) 
showed that there was no significant difference (Figure 3.2.3.1-25E). However in 
contrast, the application of 250 nM CRH led to a significant reduction of depressed 
sites (8.10 ± 6.50) compared to untreated slices (57.7 ± 19.3) (Figure 3.2.3.1-25F). 
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Figure 3.2.3.1-25. CRH-induced changes in network dynamics after HFS in the LA are partially mediated by CRHR1. A,
Significant (Mann-Whitney Rank Sum test, p = 0.029) increase of total strength of network potentiation in the presence of 250 nM
CRH in slices from CTRL mice (untreated slices: black circles vs. CRH-treated slices: open circles). B, A Significant (Mann-
Whitney Rank Sum test, p = 0.026) increase in the number of potentiated sites after HFS was observed by application of 250 nM
CRH. C, Reduction in number of depressed sites. D, The increase in total strength of network potentiation after HFS induced by
250 nM CRH in CTRL slices was abolished in CKO slices (untreated slices: black circles vs. CRH-treated slices: open circles). E,
Similarly, the increase in the number of potentiated sites after HFS in CTRL slices after application of 250 nM CRH was also
abolished in CKO slices. F, In CKO slices, 250 nM CRH induced a significant (t-test, p = 0.047) decrease in the number of
depressed sites after HFS compared to untreated slices (CTRL: n = 8 slices/5 animals, CTRL presence of 250 nM CRH: n = 10
slices/8 animals, CKO: n = 9 slices/5 animals, CKO presence of 250 nM CRH: n = 7 slices/5 animals). Data are presented as
means  SEM and all statistical comparisons were done for minutes 30-42 after HFS. CRH = Corticotropin-releasing hormone,
CRHR1 = Corticotropin-releasing hormone receptor type 1, LA = Lateral amygdala, CTRL = Crhr1loxP/loxP mice, CKO =
Crhr1loxP/loxP Camk2α-Cre mice, HFS = High-frequency stimulation.
 
Using this paradigm, the neuronal network of the BLA was also investigated with 
respect to the number of sites of potentiation after HFS.  By this means slices 
obtained from CTRL mice and treated with 250 nM CRH (32.9 ± 9.3, n = 7 slices/6 
animals) displayed no significant difference compared to untreated slices (12.1 ± 3.1, 
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n = 8 slices/5 animals) (Figure 3.2.3.1-26A). Conversely, brain slices from CKO mice 
showed a significant increase in number of potentiated sites after HFS (50.4 ± 10.0, n 
= 7 slices/5 animals) in the presence of 250 nM CRH compared to control conditions 
(22.7 ± 6.2, n = 9 slices/5 animals) (Figure 3.2.3.1-26B). 
 
 
 
 
 
 
 
 
 
Figure 3.2.3.1-26. CRHR1 is involved in mediating the effect of 250 nM CRH on network potentiation in the BLA after
HFS. A, In slices from CTRL mice, potentiated sites in the BLA did not significantly differ comparing the absence (n = 8 slices/5
animals) with the presence of 250 nM CRH (n = 7 slices/6 animals). B, Conversely, 250 nM CRH (n = 7 slices/5 animals) was
capable of significantly (t-test, p = 0.027) increasing the number of potentiated sites after HFS compared to control condition (n
= 9 slices/5 anmals) in brain slices from CKO mice. Data are presented as means  SEM. CTRL = Crhr1 loxp/loxp , CKO = Crhr1
loxp/loxp Camk2α-cre, CRHR1 = Corticotropin-releasing hormone receptor type 1, CRH = Corticotropin-releasing hormone, BLA =
Basolateral amygdala, HFS = High-frequency stimulation.
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3.2.4 Investigation of the effect of Cort on network activity and dynamics in the 
LA and BLA 
 
CRH secretion from the hypothalamus triggers ACTH release from the anterior 
pituitary gland, which in turn stimulates the release of corticosteroids such as Cort, 
from the adrenals (Fink, 2006; Bonfiglio et al., 2011). The effect of bath application of 
Cort on neuronal network activity and dynamics in the LA and BLA was investigated. 
Bath application of 100 nM Cort significantly increased FDS amplitudes in the LA 
(5.90 ± 1.40%, n = 8 slices/6 animals). In the BLA, Cort also increased FDS 
amplitudes, but this effect was not significant (3.70 ± 2.31%, n = 7 slices/6 animals) 
(Figure 3.2.4-27A, B). The analysis of neuronal network dynamics after HFS revealed 
that the application of 100 nM Cort was capable of significantly increasing the total 
strength of network potentiation (5402 ± 1259%, n = 8 slices/6 animals) compared to 
control conditions (1946 ± 515%, n = 10 slices/7 animals) in the LA (Figure 3.2.4-
27C). The total strength of network potentiation after HFS in the BLA was also 
significantly increased in the presence of 100 nM Cort (1073 ± 224%, n = 7 slices/6 
animals) compared to control slices (486 ± 125%, n = 10 slices/7 animals) (Figure 
3.2.4-27D). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3. Results                                                                                                                                               53 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2.4-27. Effects of bath application of 100 nM Cort on FDS amplitudes and total strength of network
potentiation after HFS in brain slices containing the LA and BLA. A, Bath application of 100 nM Cort significantly (paired
t-test, p = 0.004) increased FDS amplitudes in the LA. B, Although increasing the FDS amplitudes in the BLA, this effect of
Cort did not reach the level of significance. C, Compared to control slices (black circles), the presence of 100 nM Cort (open
circles) significantly (Mann-Whitney Rank Sum test, p = 0.023) increased the total strength of network potentiation in the LA by
comparing the mean values of total strength of potentiation minutes 30-42 after HFS to baseline. D, Using the same paradigm,
a significant (t-test, p = 0.026) increase of this parameter could be observed in the BLA. All data are presented as means  
SEM (LA control: n = 10 slices/7 animals, LA presence of Cort: n = 8 slices/6 animals, BLA control: n = 10 slices/7 animals,
BLA presence of Cort: n = 7 slices/6 animals). Cort = Corticosterone, FDS = Fast depolarization-mediated signal, LA = Lateral
amygdala, BLA = Basolateral amygdala, HFS = High-frequency stimulation.
 
 
The quantification of the number of potentiated sites within the LA network showed a 
significant (t-test, p = 0.003) increase comparing control slices (109 ± 22, n = 10 
slices/7 animals) with slices treated with 100 nM Cort (248 ± 34, n = 8 slices/6 
animals). In the same slices, the number of sites of depression was significantly 
(Mann-Whitney Rank Sum Test, p = 0.006) reduced comparing control slices (69.9 ± 
13.3, n = 10 slices/7 animals) with the presence of 100 nM Cort (15.9 ± 9.7, n = 8 
slices/6 animals). The neuronal network of the BLA responded with a significant (t-
test, p = 0.004) increase in the number of potentiated sites after HFS comparing 
control condition (27.4 ± 5.9, n = 10 slices/7 animals) to 100 nM Cort treatment (61.3 
± 8.4, n = 7 slices/6 animals) (data not shown).  
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3.2.5 Comparison of network dynamics in amygdalar slices obtained from HAB 
and NAB mice 
 
Since it was shown that HAB and NAB mice exhibit different levels of freezing in a 
contextual fear-conditioning paradigm (Yen et al., 2012), these mouse strains were 
tested with respect to differences in total strength of network potentiation in the LA 
and BLA after HFS. 
The comparison of network dynamics revealed that there was no significant 
difference between HAB (3600 ± 675%, n = 10 slices/6 animals) and NAB (3365 ± 
656%, n = 11 slices/6 animals) (Figure 3.2.5-28A) in the magnitude of total strength 
of network potentiation within the LA. Conversely, total strength of network 
potentiation in the BLA was significantly increased in HAB (863 ± 149%, n = 10 
slices/6 animals) compared to NAB (511 ± 83%, n = 10 slices/6 animals) mice 
(Figure 3.2.5-28B). 
A                                                        B 
 
Figure 3.2.5-28. Investigation of total strength of network potentiation after HFS comparing NAB and HAB mice. A,
After delivering a HFS, total strength of network potentiation did not significantly differ comparing NAB (black circles) with HAB
(open circles) in the LA. B, Using the same paradigm, HAB mice showed a significant (t-test, p = 0.048) increase compared to
NAB mice in the BLA. All data are presented as means  SEM (NAB: n = 11 slices/6 animals, HAB: n = 10 slices/6 animals).
HFS = High-frequency stimulation, NAB = Normal anxiety-related behaviour, HAB = High anxiety-related behaviour, LA =
Lateral amygdala, BLA = Basolateral amygdala.
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3.3 Pharmaceutical treatment 
 
Based on the observations that the strength and synchrony of neuronal activity in the 
LA and to some extend in the BLA can be related to fear (Pare and Collins, 2000; 
Repa et al., 2001; An et al., 2012; Ryan et al., 2012), chemical compounds which 
might mediate their anxiolytic effects in part by regulating neuronal activity in the LA 
or BLA, were bath applied to show their putative role in the regulation of neuronal 
network activity in these brain regions.  
Bath application of 1 µM diazepam, a positive allosteric modulator of the GABAA 
receptor (Whiting, 2006) was capable of significantly reducing LA network activity, 
reflected through a decrease in FDS amplitudes compared to baseline (13.3 ± 2.9%, 
n = 6 slices/3 animals) (Figure 3.3-29A). By use of the same paradigm, a significant 
reduction of the FDSs could also be observed in the BLA (13.0 ± 3.8%, n = 6 slices/3 
animals) (Figure 3.3-29B). 
 
 
 
 
 
 
 
 
 
Figure 3.3-29. Diazepam reduces FDS amplitudes in the LA and BLA. A, Significant (paired t-test, p = 0.006) reduction of
FDSs after bath application of 1 µM diazepam (6 slices/3 animals) in the LA. B, In the BLA, bath application of 1 µM
diazepam was capable of significantly (paired t-test, p = 0.019) reducing FDSs (6 slices/3 animals). Data are presented as
means  SEM. FDS = Fast depolarization-mediated signal, LA = Lateral amygdala, BLA = Basolateral amygdala.
 
 
Conversely, AM 404, an inhibitor of the uptake of endocannabinoids, which was 
shown to facilitate the extinction of contextual fear memory and might be a novel 
target for the treatment of anxiety disorders (Patel et al., 2004; Bitencourt et al., 
2008) exerted circuit-specific effects on FDSs. The application of 10 µM AM 404 had 
no significant effect on the FDSs in the LA (2.70 ± 2.86%, n = 5 slices/3 animals) 
(Figure 3.3-30A). In contrast, in the same slices, this treatment led to a significant 
reduction of FDSs in the BLA (5.90 ± 1.30%) (Figure 3.3-30B). 
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Figure 3.3-30. Brain region-specific effects of AM 404 on FDS amplitudes in the LA and BLA. A, Bath application of
10 µM AM 404 had no significant effect on FDSs in the LA (n = 5 slices/3 animals). B, Significant (paired t-test, p = 0.011)
reduction of FDSs caused by wash in of 10 µM AM 404 in the BLA. Data are presented as means  SEM. FDS = Fast
depolarization-mediated signal, LA = Lateral amygdala, BLA = Basolateral amygdala, AM 404 = N-(4-
Hydroxyphenyl)arachidonylamide.
 
SSRIs are a class of antidepressants which are widely used for the treatment of 
affective and anxiety disorders (Vaswani et al., 2003). One example of this class of 
medicaments is fluvoxamine. Bath application of 20 µM fluvoxamine did not 
significantly alter FDSs both in the LA (1.30 ± 3.43%, n = 5 slices/3 animals) and the 
BLA (2.90 ± 2.25%, n = 5 slices/3 animals) (Figure 3.3-31). 
 
 
 
 
 
 
 
 
 
Figure 3.3-31. Effects of bath application of fluvoxamine on FDSs in the LA and BLA. Wash in of 20 µM fluvoxamine
had no significant effects on FDSs in the LA (A) or BLA (B) (n = 5 slices/3 animals). Data are presented as means  SEM.
FDS = Fast depolarization-mediated signal, LA = Lateral amygdala, BLA = Basolateral amygdala.
 
 
Among the class of SSRIs, citalopram represents the drug which has the highest 
efficacy in inhibiting the uptake of serotonin (Vaswani et al., 2003). On the one hand, 
bath application of 15 µM citalopram significantly decreased FDSs in the LA (5.20 ± 
1.64%, n = 9 slices/6 animals) (Figure 3.3-32A). On the other hand, the same 
treatment was not capable of significantly changing the FDSs in the BLA (1.00 ± 
3.13%, n = 9 slices/6 animals) (Figure 3.3-32B). 
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Figure 3.3-32. Changes in FDSs in the LA or BLA upon bath application of citalopram. A, 15 µM citalopram was
capable of significantly (paired t-test, p = 0.013) reducing FDS amplitudes in the LA (n = 9 slices/6 animals). B, Conversely,
bath application of 15 µM citalopram had no significant effects on FDSs in the BLA (n = 9 slices/6 animals). Data are
presented as means  SEM. FDS = Fast depolarization-mediated signal, LA = Lateral amygdala, BLA = Basolateral
amygdala.
 
 
Venlafaxine, which is indicated for the treatment of a broad spectrum of anxiety 
disorders, is a SNRI (Katzman, 2004). Bath application of 5 µM venlafaxine 
significantly reduced the FDS amplitudes compared to baseline in the LA (10.5 ± 
2.0%, n = 7 slices/4 animals) and in the BLA (8.80 ± 1.30%, n = 7 slices/4 animals) 
(Figure 3.3-33). 
 
 
 
 
 
 
 
 
 
Figure 3.3-33. Effects of bath application of venlafaxine on FDSs in the LA and BLA. A, 5 µM venlafaxine was capable of
significantly (paired t-test, p = 0.002) reducing the FDSs in the LA (n = 7 slices/4 animals). B, FDSs in the BLA were
significantly (paired t-test, p < 0.001) reduced by bath application of 5 µM venlafaxine (n = 7 slices/4 animals). Data are
presented as means  SEM. FDS = Fast depolarization-mediated signal, LA = Lateral Amygdala, BLA = Basolateral amygdala.
 
 
The third class of antidepressant which was investigated here was a tricyclic 
antidepressant (TCA). This class of substances is used for the treatment of various 
forms of anxiety disorders (Zohar and Westenberg, 2000). To test their effects on the 
FDSs in the LA and BLA, 15 µM clomipramine was bath applied. Both, the LA and 
BLA were influenced by this treatment, reflected through a significant reduction of the 
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FDS amplitudes compared to baseline: in the LA (6.80 ± 1.42%, n = 6 slices/4 
animals); in the BLA (7.20 ± 1.43%, n = 6 slices/4 animals) (Figure 3.3-34). 
 
 
 
 
 
 
 
 
 
Figure 3.3-34. Clomipramine affects basal neuronal network activity reflected by a decrease of FDSs in the LA and
BLA. A, 15 µM clomipramine significantly (paired t-test, p = 0.005) decreased FDSs in the LA upon bath application (n = 6
slices/4 animals). B, The FDS amplitudes were significantly (paired t-test, p = 0.004) decreased by bath application of 15
µM clomipramine (n = 6 slices/4 animals). Data are presented as means  SEM. FDS = Fast depolarization-mediated
signal, LA = Lateral amygdala, BLA = Basolateral amygdala.
 
A disturbed regulation of activity in the LA and BLA might lead to an increase of 
activity in these nuclei as response to stress and as a result, probably, to an elevated 
incidence of psychiatric diseases such as schizophrenia (Grace, 2006). Therefore, 
the antipsychotic haloperidol at a concentration of 20 µM was bath applied and 
neuronal activity in the LA and BLA was monitored. The relative FDS amplitudes 
were significantly reduced (4.20 ± 1.10%, n = 7 slices/4 animals) in the LA and BLA 
(7.00 ± 1.69%, n = 7 slices/4 animals) (Figure 3.3-35).  
 
  
 
 
 
 
 
 
 
 
 
Figure 3.3-35. Haloperidol is capable of reducing basal neuronal network activity in the LA and BLA. A, Significant
(paired t-test, p = 0.009) reduction of FDSs by bath application of 20 µM haloperidol in the LA (n = 7 slices/4 animals). B,
Basal neuronal network activity in the BLA was also significantly (paired t-test, p = 0.006) reduced by bath application of 20
µM haloperidol (n = 7 slices/4 animals). Data are presented as means  SEM. FDS = Fast depolarization-mediated signal, LA
= Lateral amygdala, BLA = Basolateral amygdala.
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4 Discussion 
 
 
4.1 Slicing procedure and qualitative/quantitative investigation of signal 
propagation within the amygdalar neuronal network 
 
The neuronal network of the LA and BLA contained in horizontal brain slices was 
investigated in other studies performed in mice and rats (von Bohlen und Halbach 
and Albrecht, 1998; Drephal et al., 2006; Kulisch et al., 2011). Therefore, the 
anatomical landmarks described for the rat brain could be used for the mouse brain 
slice preparation employed in this study. To preserve similar neuronal networks 
across the slices, the important landmarks were the CA1 region of the intermediate 
hippocampus, the stria terminalis, and the lateral ventricle as anatomically well- 
defined brain structures (von Bohlen und Halbach and Albrecht, 1998). An additional 
and less well described landmark was a fibre bundle separating the BLA from the 
CeA. A tracing study in cats attributed this fibre bundle to parts of the intercalated cell 
masses, which regulate information flow from the BLA to the CeA via GABAergic 
inhibition (Pare and Smith, 1993). This fibre bundle can also be found in rat brain 
slices (von Bohlen und Halbach and Albrecht, 1998). 
To ensure inter-nuclear connectivity in the brain slice preparation used here, the 
spread of neuronal activity was qualitatively examined by either stimulation of the EC 
or fibres in the LA. The course of neuronal activity propagation followed the tendency 
to travel from lateral to medial and along previously described axonal projections, 
thereby validating the slicing protocol to be well suited for the investigations 
conducted here (Krettek and Price, 1978; Sah et al., 2003; LeDoux, 2007; Ehrlich et 
al., 2009; Pare and Duvarci, 2012). Additionally, the level of the LA and BLA within 
this horizontal slice preparation along the dorso-ventral axis made this neuronal 
network suitable for the study of plastic changes in neuronal excitability which might 
be associated with fear conditioning (Schafe et al., 2000; Müller et al., 2009; Wilson 
and Murphy, 2009; Orsini and Maren, 2012; Coyner et al., 2013).      
The time course of the change in fluorescence after single-pulse stimulation of the 
EC showed a FDS in the LA and BLA, which in the LA was followed by a slow 
hyperpolarisation-mediated component. The capability of Di-4-ANEPPS to report 
cellular de- and hyperpolarisation in neuronal networks has already been reported in 
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previous studies (Tominaga et al., 2000; von Wolff et al., 2011). The observation that 
slow components of the VSDI signals are affected by bath application of the GABAB 
receptor antagonist CGP 55845 is in line with electrophysiological studies that 
pointed to the occurrence of GABAB receptor-mediated currents in BLA neurons in 
rat brain slices (Rainnie et al., 1991; Washburn and Moises, 1992). Consistently with 
these observations, the GABABR1 receptor subunits could be immunocytochemically 
localised in the LA and BLA in rat brain slices (McDonald et al., 2004). 
Bath application of voltage-gated sodium channel and ionotropic glutamate receptor 
blockers (Hille, 2001) proved the FDS mediated by electrical neuronal activity and the 
prevalence of glutamatergic neurotransmission within the LA and BLA. The latter 
finding is in accordance with reports that revealed a dominance of glutamate 
signalling in the LA and BLA, which is also emphasised by the high portion of 
pyramidal-like projection neurons in these nuclei (McDonald, 1982; Sah et al., 2003). 
The small (~20% of baseline response) remaining VSDI signal after bath application 
of NBQX and AP 5 could be attributed to electrical activity of stimulated afferents. 
Abolishing fast inhibitory signalling, which is mediated via GABAA receptors in the LA 
and BLA (Rainnie et al., 1991; Wang et al., 2001), strongly increased FDS peak-
amplitude (~50% of baseline response), thus emphasizing the importance of 
GABAergic inhibition in the regulation of neuronal activity in the amygdala (Ehrlich et 
al., 2009). 
As a prerequisite for the study of activity and plasticity in subsequent experiments, 
the FDSs in the LA and BLA remained constant upon repeated evocation.  
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4.2 Investigation of neuronal network dynamics 
 
4.2.1 Verification of induction protocol 
 
It has been shown that delivery of HFS to the EC is capable of inducing LTP in the 
LA, reflected by a lasting increase in the amplitude of excitatory post-synaptic 
potentials in brain slices obtained from rats (Chapman et al., 1990). Accordingly, 
extracellular recordings of excitatory field potential in the LA in vitro showed that 
HFS, as a well-established stimulation protocol for the induction of LTP in the 
hippocampus and the amygdala (Maren, 1999; Albensi et al., 2007), succeeded in 
reliably and long-lastingly increasing evoked neuronal network activity. 
By use of a horizontal brain slice preparation, bath application of GABAA receptor 
antagonists (e.g. picrotoxin) to allow for LTP formation in the LA (Huang et al., 2000; 
Fourcaudot et al., 2009; Krishnan et al., 2010) could be circumvented. 
This finding is in line with the results of previous work done in horizontal brain slices 
prepared from rats (Drephal et al., 2006; Kulisch et al., 2011).  
 
4.2.2 Detection of amygdalar network dynamics by means of VSDI and data 
processing of VSDI movies 
 
After proving the validity of HFS as an induction protocol for long-lasting changes in 
evoked neuronal network activity in the LA, these changes were qualitatively 
investigated by means of VSDI. It was shown that after HFS stimulus-triggered 
network activity in the LA, in a spatially restricted manner, is sustained enhanced, 
reflected by a prolonged increase in FDS peak amplitude. Studies that employed 
hippocampal slices demonstrated the capacity of VSDI as a valuable tool to 
quantitatively examine changes in the strength of neuronal activity by use of different 
stimulation intensities, pharmacological intervention, and neuroplasticity-inducing 
electrical stimulation (Tominaga et al., 2000; von Wolff et al., 2011; Stepan et al., 
2012). 
The advanced processing of VSDI movies in Matlab, accounting for VSD and camera 
chipset mediated-noise, via the "Active Site Filter", enabled the restriction of further 
analysis steps to pixels, that reliably displayed depolarization-induced changes in 
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fluorescence. The fast depolarization-mediated change in fluorescence throughout 
the slice was captured by the computation of a maximum intensity projection map 
and the use of anatomical landmarks allowed for a signal detection restricted to the 
LA or BLA. 
The mean of all single relative values of these changes reflected the overall change 
in potentiation or depression. 
Since the investigation of neuronal network dynamics on the level of mean values of 
changes over all sites, which display these changes, bears the risk that the actual 
strength of changes is lost by the averaging, two other parameters were additionally 
introduced.   
First, the number of sites that displayed depression or potentiation of network activity 
was quantified. 
The second measure took both parameters into account and was calculated by 
summing up the single percentage values of sites at which potentiation or depression 
occurred. 
The quantification of neuronal network dynamics revealed that the LA responded 
spatially segregated to the same HFS with depression or potentiation. 
Due to its proximity to the stimulation electrode the network of the BLA was solely 
examined regarding potentiation. This proximity and the resultant intensive excitation 
of the BLA upon single-pulse electrical stimulation most likely override depression of 
neuronal excitability. These findings exemplify the stimulus-dependent information-
encoding capacity of the LA and the BLA on the level of the modulation of neuronal 
network activity. The observation that HFS, besides being an intensively used 
stimulation paradigm for LTP induction (Maren, 1999; Albensi et al., 2007), is also 
capable of triggering LTD of LA network activity via cortical afferents additionally 
highlights the methodological value of the VSDI assay developed here. In line with 
this observation, it has been shown on the single-cell level that projection neurons in 
the LA responded to the same stimulus with LTP or LTD of excitatory postsynaptic 
potential slope in coronal slices from mice. The authors found that these differential 
responses depended on the timing and location of synaptic activity and postsynaptic 
calcium spikes (Humeau and Lüthi, 2007). However, since the experimental 
approach developed in the present study monitors spatio-temporally restricted 
neuronal network dynamics, the observed changes in signalling might also be 
mediated by indirect signalling routes, e. g. fast feedback circuits. 
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4.2.2.1 Pharmacological characterization of changes in network dynamics 
 
Changes in amygdalar network dynamics after HFS were pharmacologically 
investigated.  
For this purpose, AP 5 or verapamil, blockers of NMDA receptors or L-VGCCs, 
respectively, were bath applied. In these studies, in which whole-cell patch-clamp 
and extracellular recordings were used, the authors could show that these treatments 
were capable of decreasing the magnitude of LTP or LTD in the LA in horizontal or 
coronal brain slices from mice (Bauer et al., 2002; Fourcaudot et al., 2009; Müller et 
al., 2009). 
On the neuronal network level within this study, AP 5 and verapamil conversely 
influenced the magnitude of LTP and LTD in the LA in a way that AP 5 increased 
network potentiation and decreased network depression. Verapamil in turn 
decreased network potentiation and increased network depression. 
On the behavioural level, infusions of AP 5 into the LA/BLA were capable of 
preventing the fear memory-enhancing effect of a stressful event in rats (Shors and 
Mathew, 1998). AP 5 was also shown to prevent the extinction of fear memory upon 
its administration to the amygdala, a process that can also be related to the formation 
of new memories (Davis et al., 2003). 
One study highlighted the presence of NMDA receptors both at pre- and postsynaptic 
membranes in the LA. By interference with calcium signalling via blockade of NMDA 
receptors or VGCCs, the authors demonstrated intracellular calcium signalling in pre-
and postsynaptic components to be involved in the regulation of auditory fear 
conditioning (Tsvetkov et al., 2002). Together with the finding that LTP and LTD are 
differentially regulated at the level of single projection neurons, dependent on the 
intracellular calcium concentration (Humeau and Lüthi, 2007), the observed 
alterations in evoked neuronal network activity might reflect a bidirectional 
modulation of LA network dynamics by the blockade of either NMDA receptors or L-
VGCCs.  
In the BLA, verapamil decreased the number of potentiated sites in comparison to 
control conditions and the presence of AP 5. This observation is in line with a study 
pointing to a minor contribution of NMDA receptors to LTP induction in the BLA. The 
authors showed that AP 5, at a concentration that is able to abolish LTP formation in 
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the CA1 region of the hippocampus and cortex, did not impact on the magnitude of 
LTP in the BLA as revealed by intracellular recordings (Chapman and Bellavance, 
1992). Conversely, a study conducted in rats demonstrated NMDA receptor 
antagonism in the BLA to be capable of blocking the acquisition of contextual fear 
memory (Fanselow and Kim, 1994).  
The finding that verapamil reduces the number of sites at which potentiation occurred 
can be related to a study in rats, in which infusions of verapamil in the BLA prevented 
the formation of extinction memory (Davis and Bauer, 2012). Putting these 
observations together, the present in vitro investigation of the processing units LA 
and BLA offers a promising approach to dissect network activity and dynamics under 
distinct conditions.   
 
4.2.3 Effect of CRH on LA and BLA network activity and dynamics 
 
Bath application of 125 nM or 250 nM CRH differentially influenced neuronal network 
activity and dynamics in the amygdala. 
The CRH concentrations employed were in the range that has previously been 
shown to elicit an increase in spike frequency in pyramidal cells of the hippocampus 
in rat brain slices (Aldenhoff et al., 1983). Such an enhancement in spiking activity 
could also be observed in the hippocampus (Kratzer et al., 2013). Moreover, in 
coronal brain slices from mice containing the BLA, bath application of 125 nM CRH 
significantly increased the amplitude of field potentials evoked by stimulation of the 
LA. This effect was mediated via CRHR1 (Refojo et al., 2011).  
On the level of neuronal network activity, bath application of CRH, concentration- 
dependently increased FDS amplitudes in the LA and BLA. This effect might arise 
from a CRH-induced alteration in the responsiveness of neurons to 
neurotransmitters, an altered release probability of neurotransmitters, a decrease in 
GABAergic inhibition and elevated intrinsic spiking capacities of neurons (Rainnie et 
al., 2004; Gallagher et al., 2008; Kratzer et al., 2013). The observation that 250 nM 
CRH significantly increase FDS amplitudes in the BLA offers a circuit-level 
description of the effect of this stress hormone on the activity of this neuronal 
network. A similar action of 125 CRH was previously found on the level of evoked 
neuronal activity, reflected by excitatory field potentials recorded in brain slices from 
mice (Refojo et al., 2011). Although, in this study, neuronal activity in coronal slices 
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containing the BLA was evoked by intra-nuclear stimulation of the LA, in contrast to 
EC stimulation in horizontal slices as done in the present work, the same tendency in 
change of activity could be observed. 
In the context of fear conditioning, it has been previously reported that the 
presentation of once learned fear-associated cues elevates in vivo levels of CRH in 
the BLA. Thereby, the authors related the behavioural expression of fear to an 
increase in CRH levels in this circuitry (Mountney et al., 2011). 
After induction of plastic changes by HFS it was observed that the presence of CRH 
concentration-dependently affected neuronal network plasticity in the LA. 
Several in vivo studies point to the involvement of endogenous CRH, probably 
released by neurons of the CeA, in the regulation of fear memory consolidation within 
the LA and BLA (Roozendaal et al., 2002; Shekhar et al., 2005; Hubbard et al., 2007; 
Isogawa et al., 2013). In this study, bath application of CRH before HFS possibly 
mimics the release of CRH from the CeA in the LA and BLA during stressful 
conditions (Roozendaal et al., 2002; Isogawa et al., 2013). 
By use of the developed VSDI assay, in conjunction with advanced data processing, 
CRH-mediated changes after HFS could be observed on different levels. 125 nM 
CRH was capable of significantly increasing the mean relative change of network 
potentiation, but not of affecting the number of potentiated or depressed sites. In 
contrast, in the presence of 250 nM CRH, the network dynamics after HFS were 
reshaped. This was reflected by a significant increase in the number of potentiated 
sites and a significant reduction in the number of depressed sites. As a 
consequence, total potentiation, which reflects both the strength of potentiation and 
the number of sites at which the changes occur, was significantly increased. 
Conversely, the presence of 125 nM or 250 nM CRH had no significant influence on 
the formation of potentiated sites after HFS in the BLA.  
The enhancing effect of CRH on network plasticity within the LA is in line with a study 
in which the authors showed that 125 nM CRH enhanced the magnitude of 
population spike LTP in the hippocampus in vitro (Blank et al., 2002). Other studies 
correlated CRH effects and LTP on the level of their partial share in regulating 
intracellular signalling cascades in the dentate gyrus of the hippocampus, which 
included the enhancement of adenylyl-cyclase activity and a higher rate of protein 
phosphorylation (Dave et al., 1985; Hung et al., 1992; Wang et al., 2000). 
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Experiments performed in rat coronal brain slices showed that the presence of 25 nM 
CRH in the bathing solution leads to an increased magnitude of HFS-induced LTP of 
excitatory field potentials in the LA. The authors conducted these experiments in 
animals that had a history of cocaine consumption and were withdrawn from this 
drug. In this respect, this study points to an involvement of dopamine receptors in the 
enhancing effect of CRH on LTP, namely mediated via a decrease in neuronal 
inhibition (Krishnan et al., 2010). Accordingly, an involvement of dopamine-gated 
inhibitory circuits in the control of LA excitability was shown by a study that employed 
coronal slices from mice (Marowsky et al., 2005). Furthermore, urocortin, a potent 
CRH receptor agonist, was infused into the BLA in rats, and 5 days after this 
treatment the animals exhibited enhanced anxiety-related behaviour, which persisted 
for >30 days and could be correlated with a decrease in the amplitude of 
spontaneous and evoked inhibitory post-synaptic potentials as revealed by whole-cell 
patch-clamp recordings in coronal brain slices. The authors also showed that this 
lasting reduction could be blocked by the NMDA receptor antagonist AP 5 and 
CaMKII inhibition by 1-[N, O,-bis-(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-
phenylpiperazine (Rainnie et al., 2004). 
In addition to these observations, it has been reported that in vivo administration of 
CRH into mouse brains results in a phosphorylation of the ERK 1/2, intracellular 
kinases of the MAPK superfamily, in the LA and BLA, pointing to an increased 
activity of these kinases (Refojo et al., 2005). 
Moreover, infusions of CRH into the BLA of rats and subsequent behavioural testing 
in an inhibitory avoidance test revealed that CRH enhances the memory retention 
latency. By treatment with the β-adrenoceptor antagonist atenolol the authors could 
link the CRH effect with this receptor type and its downstream intracellular target 
cAMP (Roozendaal et al., 2008). 
From the studies described above it becomes likely that the magnitude of LA LTP in 
the presence of CRH can be modulated by several molecular pathways and also 
critically depends on the balance between excitation and inhibition.  
The observed increase in basal neuronal activity reflected by the enhancement of 
FDS amplitudes by 250 nM CRH can also be interpreted in such a way that a larger 
portion of neurons is included in the pool of neurons, which can be potentiated in 
their excitability by HFS. This interpretation fits to a biophysical model, which 
correlates the intrinsic excitability of LA neurons with their capability to be integrated 
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into a fear memory trace. Although this study pointed to a relatively constant number 
of neurons within such traces (Kim et al., 2013), CRH concentrations used in vitro 
might counteract the mechanisms that balance this system. The finding that 250 nM 
significantly reduces the number of depressed sites in the LA can be brought in line 
with a study performed in mice. This study employed safety learning paradigms by 
pairing a CS with a safe environment. In vivo electrophysiological recordings 
demonstrated a CS-evoked long-term depression of LA single unit activity, which was 
accompanied by the behavioural expression of a positive affect (Rogan et al., 2005). 
Taking this data together with the effect of CRH on the enhancement of retention 
latency of fear memories in rats (Roozendaal et al., 2008), unrevealed alterations in 
LA dynamics may provide a circuit-level mechanism for the impact of CRH on fear 
memory modulation. 
The finding that CRH had no significant effect on the number of potentiated sites in 
the BLA after HFS might be interpreted in that way that, although EC stimulation 
directly provokes neuronal activity in the BLA along the known connectivity (Sah et 
al., 2003), GABAergic projections from the LA could in addition indirectly modulate 
BLA activity. In this way BLA FDS amplitudes could be decreased and, thereby, a 
significant increase in the number of potentiated sites after HFS could be prevented 
in the presence of 250 nM CRH.  
All findings regarding the effect of CRH on network dynamics should be interpreted 
cautiously with respect to fear conditioning since a study in rats shows that infusions 
of this peptide into the LA differentially impacts on fear memory acquisition and 
expression, depending on the timing of its administration relative to the conditioning 
procedure (Isogawa et al., 2013). 
 
4.2.3.1 Dissection of the involvement of CRHR1 in the observed changes in 
network activity and dynamics 
 
250 nM CRH was capable of increasing FDSs in the LA and BLA in CTRL mice. 
These effects were abolished in CKO mice. This finding is in line with studies having 
provided evidence for an involvement of CRHR1 in the regulation of excitatory neuro-
transmission (Ugolini et al., 2008; Refojo et al., 2011). 
Next, HFS was applied in the presence of 250 nM CRH to the EC in brain slices from 
CTRL mice and similar results as in Bl 6 mice were obtained with respect to the total 
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strength of network potentiation and the number of potentiated sites. Although the 
decrease in the number of sites of depression in the presence of 250 nM CRH did 
not reach the level of significance, the observed effect followed the same tendency 
as in brain slices from Bl 6 mice. An explanation for this difference might be slight 
variations in the LA circuitry preserved in the brain slices. This explanation is 
favoured by a p-value of 0.05 in the respective statistical comparison. 
The use of brain slices, in which the CRHR1 gene was selectively deleted in 
projection neurons in the forebrain, revealed that CRHR1 was involved in CRH-
induced changes in network potentiation in the LA after HFS, whereas the reduction 
of depressed sites in the presence of CRH was unchanged.   
In the BLA from CTRL mice, no significant differences in the number of potentiated 
sites after HFS in the presence of 250 nM CRH could be found, but, on the contrary, 
CKO mice showed a significant increase in the number of potentiated sites.  
Influence of CRHR1 on LA network potentiation could possibly be related to its 
function as class “B” G-protein-coupled receptor. Thereby, this receptor may 
modulate various intracellular signalling cascades, some of which were also shown to 
be involved in the regulation of synaptic plasticity in the LA (Gallagher et al., 2008; 
Johansen et al., 2011).  
The reduction of depressed sites in the LA within slices from KO mice could point to 
an involvement of CRHR2, the function of which was attributed to a depression of 
glutamatergic neurotransmission (Gallagher et al., 2008). The CRH-induced 
significant increase in the number of potentiated sites after HFS in the BLA within 
brain slices from CKO mice could be due to a decrease in inhibition arising from 
CRHR1-expressing neuronal circuits in the LA, which, in the presence of CRH, 
increase their inhibitory output.  
On the behavioural level, forebrain deletion of the CRHR1 gene could be related to a 
reduction of anxiety-related behaviour and infusions of a specific CRHR1 antagonist 
([9-41]-α-helical CRH) into the BLA of rats, immediately after fear conditioning 
impaired the retention of fear memory (Roozendaal et al., 2002; Refojo et al., 2011). 
Moreover, elevated anxiety-related behaviour in the presence of a molecule that 
binds to CRHR1, namely urocortin (infused into the BLA), was prevented by co-
application of the CRHRs antagonist astressin in rats (Sajdyk and Gehlert, 2000). 
Altogether, the findings of the present work provide additional evidence for CRHR1 
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antagonists being promising therapeutics for the treatment of anxiety disorders 
(Holsboer and Ising, 2008; Kehne and Cain, 2010).  
 
4.2.4 Effect of Cort on LA and BLA network activity and dynamics  
 
Bath application of Cort at a concentration of 100 nM, which lies in the range of other 
doses used in in vitro studies (Karst et al., 2002; Duvarci and Pare, 2007; Stepan et 
al., 2012) increased FDS amplitudes in the LA and BLA. Moreover, both nuclei 
exhibited an enhancement in network potentiation, reflected by an increase in total 
potentiation and the number of potentiated sites. In addition, Cort decreased the 
number of sites of depression in the LA. Due to its rapid onset (Makara and Haller, 
2001), the increase in FDS amplitudes after wash in of 100 nM Cort probably reflects 
non-genomic effects. In vitro studies performed in the BLA contained in rat brain 
slices showed that bath application of Cort is able to increase the excitability of 
principal neurons. This increase was partly mediated by a depolarized resting 
membrane potential and indirectly through a reduction of GABAA receptor-mediated 
IPSPs. The latter effect was attributed to a positive shift in the reversal potential of 
chloride (Duvarci and Pare, 2007).  
Genomic effects of in vitro administration of Cort, which were linked to a modulation 
of ion channel endowment of BLA principal neurons, could be related to an alteration 
in the transcription of the α1 subunit of L-VGCCs. These observations were made in 
coronal brain slices from rats (Karst et al., 2002). 
On the behavioural level, several observations point to an involvement of Cort in the 
amygdala in the modulation of fear- and anxiety-related behaviour. Experiments 
conducted in rats showed that infusions of Cort into the BLA increase anxiety-related 
behaviour as revealed by a decreased percentage of time spent in the open arm of 
the elevated-plus maze (Mitra and Sapolsky, 2008). The specific involvement of the 
BLA in the mediation of Cort-induced enhancement of fear memory was postulated 
by a study performed in rats (Quirarte et al., 1997). In vivo testing of the influence of 
post-training infusions of Cort within an auditory fear-conditioning paradigm into the 
BLA of rats revealed that this treatment is capable of increasing the retention latency 
of acquired fear memory. The authors further related this enhancement to the 
activation of β1 adrenoceptors (Roozendaal et al., 2006).  
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In the light of these findings, the changes observed here in neuronal network activity 
and dynamics in the LA and BLA could reflect non-genomic effects of Cort 
application. Interestingly, on the level of investigation of electrical activity, 100 nM 
Cort, similar to 250 nM CRH, increased network potentiation and decreased network 
depression in the LA. This effect might be due to a modulation of L-VGCCs and the 
concomitant alteration of calcium influx into neurons which at least in part might 
underlie the changes in network dynamics, and thus, contribute differentially to LTP 
and LTD formation in the LA (Humeau and Lüthi, 2007). 
 
4.2.5 Differences in network dynamics in the LA and BLA of HAB/NAB mice 
 
The use of brain slices from HAB or NAB mice and concomitant investigation of 
network dynamics in the LA and BLA revealed that these amygdaloid circuits 
differentially responded to HFS. LA total strength of network potentiation was not 
significantly altered after HFS, whereas the circuitry of the BLA displayed a 
significant increase in network potentiation in HAB mice compared to NAB mice. 
On the molecular level, this observation is in line with a study which reported an 
increase in the phosphorylation of PKB in the BLA after contextual fear conditioning 
in brain tissue from HAB compared to NAB mice (Yen et al., 2012). By referring to 
observations that the activation of PKB can be involved in cellular processes 
triggered by fear conditioning and in vitro LTP induction (Lin et al., 2001), the 
dissociation on the level of network potentiation between the LA and BLA in the 
present work with respect to HAB/NAB mice may partly be governed by such 
mechanisms. Additionally, in another study, mice were selected and bidirectionally 
bred with respect to their magnitude of freezing within an auditory fear conditioning 
paradigm. Mice that showed elevated freezing behaviour upon the presentation of 
the CS also showed an increase in molecular markers reflecting neuronal activity, 
such as ERK1/2 in the dorsal part of the LA compared to the medial and ventral part 
of the LA (Coyner et al., 2013). 
Moreover, a study in humans compared the startle potentiation of subjects with high 
trait anxiety with low trait anxiety personalities by use of a fear conditioning paradigm. 
The authors could show that high-anxious individuals tended to acquire conditioned 
cues associated with a certain context much faster than less anxious subjects 
(Glotzbach-Schoon et al., 2013). Taken these observations together, the observed 
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differences in LA and BLA network dynamics between HAB and NAB mice could 
reflect a functional dissociation of these nuclei in their fear memory-encoding 
capacity, dependent on the basal anxiety level. 
 
4.3 Pharmaceutical treatment 
 
Bath application of distinct pharmaceuticals and subsequent investigation of their 
influence on LA and BLA network activity, revealed their potential to differentially 
affect these electrophysiological measures. 
A medication, whose mechanism action has been elucidated on the level of synaptic 
transmission, is diazepam (Whiting, 2006). As a positive allosteric modulator of 
GABAA receptors bath application of diazepam is capable of reducing FDS 
amplitudes both in the LA and BLA. These findings are in line with the prominent role 
of inhibitory neurotransmission in the regulation of LA and BLA activity and, from a 
clinical point of view, the use of this substance as an anxiolytic (Whiting, 2006; 
Ehrlich et al., 2009). 
The endocannabinoid uptake inhibitor (Giuffrida et al., 2001) AM 404 differentially 
influenced neuronal network activity in the LA and BLA. LA neuronal network activity 
was not significantly altered, FDS amplitudes in the BLA were significantly reduced. 
Given the observations that LA and BLA circuits differentially contribute to distinct 
forms of fear conditioning (Yen et al., 2012; Coyner et al., 2013) and that AM 404 is 
able to facilitate the extinction of contextual fear memory (de Bitencourt et al., 2008), 
the observed effect of AM 404 on BLA network activity might reflect a circuit level 
mechanism for the influence of this drug on fear memory. 
Bath application of fluvoxamine or citalopram as member of the SSRIs (Burghardt 
and Bauer, 2013) affected FDS amplitudes in that way that only citalopram 
decreased network activity in the LA. These antidepressants were reported to affect 
different stages of amygdala-dependent fear memory formation. Acute treatment with 
SSRIs facilitated the acquisition and expression of fear memory, whereas chronic 
treatment impaired its expression (Burghardt and Bauer, 2013). 
The observation that fluvoxamine failed to affect LA and BLA network activity could 
be related to a study demonstrating that this substance only effectively inhibited 
conditioned freezing in rats in the presence of a serotonin receptor agonist (Li et al., 
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2001). Furthermore, with respect to its use in humans, fluvoxamine is not explicitly 
recommended for the treatment of anxiety disorders (Benkert and Hippius, 2011). 
Belonging to the same class of pharmaceuticals, citalopram significantly reduced 
FDS amplitudes in the LA but failed to exert an effect on the BLA. Several studies 
provided evidence that citalopram changes amygdalar plasticity, as reflected by the 
outcome of fear conditioning paradigms. For instance, chronic intraperitoneal 
injections of citalopram in rats led to an impairment in the acquisition of extinction 
memory (Burghardt et al., 2013). Conversely, microinjections of citalopram into the 
amygdala of rats and subsequent behavioural testing of the animals by means of a 
contextual fear-conditioning paradigm revealed that this treatment was capable of 
significantly reducing freezing behaviour (Inoue et al., 2004). 
Despite these contradictory observations there is a consensus that chronic SSRI 
treatment affects the electrical activity in the LA and BLA by regulating glutamatergic 
signalling (Burghardt and Bauer, 2013). 
The observed reduction of FDS amplitudes in the LA by citalopram might possibly 
reflect a dampening of LA signalling as response to sensory inputs, which in turn 
could influence downstream signalling in the amygdaloid complex, leading to a 
reduction of fear and anxiety. This putative mechanism of action in the amygdala was 
also recently stated by Outhred et al (2013).  The frequent use of citalopram for the 
treatment of anxiety disorders in humans also speaks in favour of this hypothesis 
(Benkert and Hippius, 2011).   
Bath application of venlafaxine as an exponent of the class of SNRIs (Katzman, 
2004) exerted a significant reduction of LA and BLA FDS amplitudes. Acute 
intraperitoneal injections of venlafaxine in rats before extinction training of auditory 
fear memory facilitated the reduction of freezing behaviour. In the same study, 
chronic venlafaxine treatment prevented the recovery of once extinguished fear 
memory (Yang et al., 2012). Venlafaxine is widely approved in pharmacotherapy of 
anxiety disorders in humans. (Katzman, 2004; Katzman, 2009; Ravindran and Stein, 
2010; Benkert and Hippius, 2011). Thus the observed changes in network activity in 
the LA and BLA might point to a circuit-level mechanism of action by which 
venlafaxine contributes to ameliorate the symptoms of these disorders. 
Clomipramine as a TCA (Zohar and Westenberg, 2000) was capable of significantly 
reducing FDS amplitude in the LA and BLA. Interestingly, there is a report 
demonstrating that delivering clomipramine chronically with the drinking water to rats, 
4. Discussion                                                                                                                                         73  
 
which were afterwards subjected to repeated restraint stress, increased their levels of 
anxiety. The authors point to an altered regulation of Na+/K+-ATPase activity in the 
cerebral cortex, which they associated with putatively occurring side effects of this 
substance during chronic treatment (Balk Rde et al., 2011). Nevertheless, the 
observed changes within the present study point to a dampening of neuronal network 
activity in the LA and BLA by this substance, an effect by which patients suffering 
from anxiety disorders might benefit from this treatment. This is also emphasised by 
its therapeutic employment (Zohar and Westenberg, 2000; Benkert and Hippius, 
2011). 
The widely used antipsychotic haloperidol (Mailman and Murth, 2010) was capable of 
significantly decreasing FDS amplitudes, both in the LA and BLA. Several studies 
point to an involvement of the glutamatergic system in schizophrenia, possibly on the 
level of diminished NMDA receptor function (Tsai and Coyle, 2002). In this context it 
is worth mentioning a study employing a mouse model in which a ketamine-induced 
hypofunction of the glutamatergic system was elicited by injection of this substance 
into mice. As a consequence, the animals showed a disruption of fear-conditioned 
responses, which was related to schizophrenia-associated emotional blunting. The 
authors further report that injections of haloperidol intraperitoneally partially rescued 
the ketamine-induced decrease in neuronal activity as indirectly revealed by c-fos 
immunolabelling (Pietersen et al., 2007). 
In the context of fear memory, there are studies describing an inhibitory influence of 
subcutaneous haloperidol injections in rats on the acquisition of the contextual cue, 
reflected by a decrease in freezing behaviour after conditioning (Inoue et al., 1996; 
Inoue et al., 2005). Therefore, the observed reduction in FDS amplitudes in the LA 
and BLA in response to haloperidol treatment could be interpreted that this would 
counteract the enhancement of neuronal activity through putative miss-associated 
fear-memory formation. Efforts to develop new strategies for pharmaceuticals for the 
treatment of schizophrenia underscore this finding (Mailman and Murthy, 2010). 
In conclusion, the observed changes in BLA and LA activity upon pharmacological 
intervention confirm this experimental approach as being useful to gain further 
insights into the action profile of various neuroactive substances. Based on the 
emerging role of the glutamatergic system governing parts of the mechanisms of 
action of some of these pharmaceuticals, the observed changes possibly reflect the 
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sum of all cellular events regulating the excitability of the processing units LA and 
BLA.  
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5. Conclusion 
 
The development of an in vitro VSDI assay in conjunction with advanced data 
processing have succeeded in providing a method by which neuronal network activity 
in the LA and BLA can specifically and reliably be investigated with high spatial and 
temporal resolution. The detection capacity achieved by the data-processing 
algorithms and the resultant tracing of lasting changes in network excitability 
resembles an "optical multi-electrode array". By this means, new insights into the 
information-encoding capacity of the LA, and in part the BLA, could be gained. These 
data point to the ability of these circuits to dynamically respond to incoming signals in 
distinct ways, a scenario supported by findings from previous studies performed on 
the single-cell level but, until now, has not been systematically examined on the 
whole network level. The uncovered changes in neuronal network dynamics could be 
correlated with known cellular mechanisms, thereby underpinning the methodological 
value of this assay. By application of mediators of the stress response, it could be 
shown that the processing units LA and BLA respond with an increase in neuronal 
network activity and a shift in the tuning of these nuclei towards a potentiation of 
excitability. This finding could be related to a circuit-level mechanism for the 
modulation of fear, fear memory, and anxiety-related behaviour by stress and also 
correlated in part with an involvement of CRHR1. 
Observed differences in information-encoding capacities of animals that differ in 
anxiety-related behaviour within distinct amygdalar circuitries could provide new 
insights into the differential information-encoding capacity of amygdalar nuclei. 
Finally, substances frequently used in the pharmacotherapy of anxiety disorders 
were found to dampen the excitability of LA and BLA circuits. Therefore, a novel 
mechanism of action could be elucidated.  
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Chemical Solvent Fabricant 
D (−)-2-Amino-5-phosphonopentanoic 
acid 
(AP 5) 
Distilled water Abcam 
N-(4-
Hydroxyphenyl)arachidonylamide 
(AM 404) 
DMSO Tocris 
Bicuculline methiodide (BIM) Distilled water Sigma 
Citalopram hydrobromide Distilled water Sigma 
Corticosterone 
(Cort) 
DMSO Sigma 
Corticotropin-releasing hormone 
(CRH) 
Distilled water Abcam 
Clomipramine Distilled water Sigma 
(2S)-3-[[(1S)-1-(3,4-Dichlorophenyl-
)ethyl]amino-2-
hydroxypropyl](phenylmethyl)phosphi-
nic acid hydrochloride 
(CGP 55845) 
DMSO Tocris 
Dimethylsulfoxide (dry) 
(DMSO) 
 Sigma 
4-(2-(6-(Dibutylamino)-2-naphtalenyl)-
1-(3-sulfopropyl) pyridinium hydroxide 
inner salt 
(Di-4-ANEPPS) 
DMSO Sigma 
Diazepam DMSO Sigma 
Fluvoxamine maleat Distilled water Sigma 
Haloperidol Distilled water Sigma 
2,3-dihydroxy-6-nitro-7-sulfamoyl-
benzo[f]quinoxaline-2,3-dione 
(NBQX) 
 
DMSO Abcam 
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Salts for ACSF- 
solutions 
Distilled Water Sigma 
Tetrodotoxin 
(TTX) 
Distilled water Sigma 
Venlafaxine hydrochloride Distilled water Sigma 
Verapamil Distilled water Sigma 
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8. Abbreviations 
 
nACSF = Artificial cerebrospinal fluid 
sACSF = Sucrose-based artificial cerebrospinal fluid 
ACTH = Adrenocorticotropic hormone 
AMPA = α-amino-3-hydroxy-5-methly-4-isoxazolepropionic acid 
AM 404 = N-(4-Hydroxyphenyl) arachidonylamide 
AP 5 = D(-)-2-Amino-5-phosphopentanoic acid 
AVP = Arginine vasopressin 
BLA = Basolateral amygdala 
BIM = Bicuculline methiodide 
Bl 6 = C57BL/6N mice 
CaMKII = Calcium/calmodulin protein kinase 
cAMP = Cyclic adenosine monophosphate  
CCD = Charge-coupled device 
CeA = Central amygdala 
lCe = Centrolateral amygdala 
mCe = Centromedial amygdala 
CGP 55845 = (2S)-3-[[(1S)-1-(3,4-Dichlorophenly-)ethyl]amino-2-
hydroxypropyl](phenylmethyl)phosphinic acid hydrochloride 
CKO = Crhr1loxP/loxP Camk2α-Cre mice 
Cort = Corticosterone 
CRH = Corticotropin-releasing hormone 
CRHR1 = Corticotropin-releasing hormone receptor type 1 
CRHR2 = Corticotropin-releasing hormone receptor type 2 
CS = Conditioned stimulus 
CTRL = Crhr1loxP/loxP mice 
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Di-4-ANEPPS = 4-(2-(6-(Dibutylamino)-2-naphtalenyl)-1-(3-sulfopropyl) pyridinium 
hydroxide inner salt  
DMSO = Dimethlysulfoxide 
EC = External capsule 
ERK = Extracellular-signal regulated kinase 
FDS = Fast depolarization-mediated signal 
GABA = Gamma-aminobutyric acid 
GR = Glucocorticoid receptor 
HAB = High anxiety-related behaviour 
HFS = High-frequency stimulation 
HPA = Hypothalamic-pituitary-adrenal  
IC = Internal capsule 
LA = Lateral amygdala 
L-VGCC = L-type voltage-gated calcium channel 
LTD = Long-term depression 
LTP = Long-term potentiation 
MAP Kinases = Mitogen-activated protein kinases 
MR = Mineralocorticoid receptor 
NAB = Normal anxiety-related behaviour 
NBQX = 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline-2,3-dione 
NMDA = N-methly-D-aspartate 
NO = Nitric oxide 
PKA = Protein kinase A 
PKB = Protein kinase B 
PKC = Protein kinase C 
PLC = Phospholipase C 
PVN = Paraventricular nucleus 
RMS = Root-mean square 
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ROI = Region of interest 
RT = Room temperature 
SNRI = Serotonin noradrenalin reuptake inhibitor 
SSRI = Selective serotonin reuptake inhibitor 
TCA = Tricyclic antidepressant 
TTX = Tetrodotoxine 
US = Unconditioned stimulus 
VGCC = Voltage-gated calcium channel 
VSD = Voltage-sensitive dye 
VSDI = Voltage-sensitive dye imaging 
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